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1  Introduction 
 
1.1 Oral potentially malignant disorders: a group of disorders of diverse 
etiologies 
 
Although numerous scientific data demonstrates bacterial colonization of cancerous tissue, in 
most cases the role of bacteria in carcinogenesis remains to be established. In humans, 
Helicobacter pylori is the only bacterium recognised as the causative agent of a malignant 
disease, gastric adenocarcinoma [1]. Thus, Helicobacter pylori has been classified as a class I 
carcinogen.  
As to the carcinomas of the head and neck region, the role of oral microbes in the 
development of oral potentially malignant disorders (OPMDs) and oral squamous cell 
carcinoma (OSCC) is periodically reevaluated, since OPMD or OSCC may develop in the 
absence of the traditional risk factors like smoking, alcohol consumption and betel nut use [2–
4]. While the microbiological background of oral squamous cell carcinoma was intensively 
studied in the last two decades, less attention has been paid to OPMD in this respect [5]. 
OPMD is a group of disorders of diverse etiologies, frequently associated with tobacco 
consumption and mutations in the DNA of oral epithelial cells. A fraction of OPMDs 
undergoes clinical and histomorphological alterations that lead to the development of OSCC. 
In 1978, working group of WHO classified „oral precancer‟ into „lesions‟ and „conditions‟ 
with following definitions: A precancerous lesion is „a morphologically altered tissue in 
which oral cancer is more likely to occur than in its apparently normal counterpart‟. A 
precancerous condition is „a generalized state associated with a significantly increased risk of 
cancer”. The current Working Group of WHO (2005) does not favour subdividing precancer 
to lesions and conditions and the consensus view was to refer to all clinical presentations that 
carry a risk of cancer under the term „oral potentially malignant disorders” (OPMD) to reflect 
their widespread anatomical distribution. These disorders include leukoplakia, erythroplakia, 
oral lichen planus, submucous fibrosis, and actinic cheilitis [6, 7]. In addition, inherited 
cancer syndromes such as xeroderma pigmentosum and Fanconi‟s anemia are also associated 
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with an increased incidence of malignant tumors, among them oral carcinoma [7]. In most 
type of OPMD we know the etiological factors of the disease, whereas in other cases the 
etiology is only partially clear (oral lichen planus), or not clear yet (proliferative verrucous 
leukoplakia). The most intensely studied infectious agent implicated in the development of 
OPMD and OSCC is HPV (human papilloma virus). There are demonstrative results in the 
literature regarding the presence of HPV in OPMD and OSCC lesions (Table 1). Table 1. also 
shows, however, that in a significant fraction of the OPMD and OSCC samples analysed, 
HPV could not be detected. For this reason, we looked for bacteria, another potential 
etiological factor, in OPMD lesions [8]. 
Table 1 Presence of HPV DNA in OPMD and OSCC lesions in literature [8] 
Disorder/disease Presence of HPV DNA 
(in % of examined 
samples) 
 
  
Lichen planus 23-32,8 % [98, 99] 
Leukoplakia/proliferative verrucous 
leukoplakia 
25,4-40,9/26,5-40,8 % [98-101] 
Erythroplakia 54,5 % [102] 
Oral squamous cell carcinoma 47,7 % [99, 102] 
 
Leukoplakia and oral lichen planus (OLP) are the most frequent OPMDs in our clinical 
practice at the Department of Oral Medicine, Faculty of Dentistry, University of Szeged. Both 
disorders appear as whitish coloured hyperkeratosis, similarly to some other OPMDs. From 
the point of view of clinical differential diagnostics, this group of OPMDs belongs to a 
„Potentially malignant and malignant” subgroup (leukoplakias, submucosal fibrosis, lichen 
planus, lupus erythematosus, epidermoid carcinoma, verrucous carcinoma) of so called 
„White lesions”. The group of „White lesions” also includes additional subgroups, such as the 
„Congenital”, „Aquired infectious and non-infectios”, and „Other” subgroups containing 
diseases with different etiologies. The possible cause of the whitish colour of „White lesions” 
could be hyperkeratosis, pseudomembranous infection or inflammation. Due to the 
heterogenity of diseases with the same clinical feature, clinical diagnostics of white lesions 
could be very difficult. Thus, quite frequently, pathological or microbiological support is 
needed to make a proper diagnosis, prognosis and treatment plan. [9] 
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1.1.1 Leukoplakia 
 
Leukoplakia is defined as ″A white plaque of questionable risk having excluded (other) 
known diseases or disorders that carry no increased risk for cancer″. Leukoplakia is six times 
more common among smokers than among non-smokers [7]. These lesions are divided into 
homogenous (simplex) and non-homogenous types. The non-homogenous types based on the 
cellular variability are verrucous leukoplakia, nodular leukoplakia and erythroleukoplakia [9]. 
Proliferative verrucous leukoplakia (PVL) is a subtype of verrucous leukoplakia that shows 
resistance to treatment and a high rate of malignant transformation. It is more frequent among 
elderly women, in many cases without smoking and consumption of alcohol in the anamnesis. 
Distinct histopathological changes, like hyperkeratosis with or without dysplasia, may 
accompany the transition of PVL to verrucous hyperplasia and verrucous carcinoma [7]. 
There are conflicting results regarding the association of leukoplakia and human 
papillomavirus (HPV) infection [7, 10]. The role of torque teno virus (TTV) [11-13], Epstein-
Barr virus (EBV) [14] and Candida albicans [10, 15–19] in leukoplakia development and 
carcinogenesis remains to be clarified, too. Additionally, it was suggested that specific 
bacterial infections like Helicobacter pylori [20], or the intracellular Mycoplasma salivarium 
[21] could also be involved in this process. 
As to the putative role of bacterial infection in oral carcinogenesis, one may speculate that it 
could be a process analogous to Helicobacter pylori infection of stomach which predisposes 
to the development of gastric cancer. Thus, an in vivo murine model of Helicobacter pylori 
induced mucosal lesions could potentially mimic the lesions caused by other bacteria or 
bacterial communities on oral mucosal surfaces (see 4.1.2). As a matter of fact, a disbalance 
in the oral microbial flora may play a role in the development of leukoplakia and 
carcinogenesis, as suggested by the association of periodontal inflammation with leukoplakia 
[22] and a changing bacterial flora in the saliva and on the oral mucosal surfaces of patients 
with OPMD [23, 24].  
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1.1.2 Oral lichen planus 
 
Lichen planus (LP) is a chronic, idiopathic, inflammatory disease of the oral mucosa or the 
skin, presenting as a white lesion when it affects the oral cavity (oral lichen planus, OLP). A 
crucial aspect of the pathomechanism of OLP is the accumulation of CD8+ T lymphocytes 
under the basal cell layer of the oral mucosa, which causes DNA damage and keratinocyte 
apoptosis by antigen-specific cell-mediated immune response. CD8+ T cells degrade the 
basement membrane as well [25–28]. According to the most accepted hypothesis, chronic 
stimulation from inflammatory and stromal cells provides the initial signal which leads to the 
uncontrolled growth of epithelial cells. Additionally, oxidative stress induced DNA damage 
could also lead to neoplastic changes, but the initial event leading to this signal cascade 
activation has not been characterized yet. Based on several lines of evidence, viral, fungal, 
and bacterial antigens have all been suggested [29–37] as a potential initiating factor in LP. If 
there is a relationship between the bacterial flora and OLP, the question is whether the trigger 
area is in the oral cavity, or at another area of the body, such as the skin and the genitals, the 
gastrointestinal tract, the larynx or the eyes. If oral bacterial infection could initiate OLP 
development, it is not clear whether a single bacterial species could initiate the OLP 
transformations, or the interaction of several species elicits this process. Additionally, the 
disturbed balance of the normal bacterial flora could also be involved in the initial steps of 
OLP activation.  
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1.2 Microbiota, microbiome, metagenome of healthy oral mucosa 
 
The term „Microbiota” means the assemblage of microorganisms present in a defined 
environment. ”Metagenome” is the collection of genomes and genes from the members of a 
microbiota. „Microbiome” refers to the entire habitat, including the microorganisms (bacteria, 
archaea, lower and higher eurkaryotes, and viruses), their genomes (i.e., genes), and the 
surrounding environmental conditions [38]. It is worth to note that there is an important 
difference between the cultivation-based and the direct sequencing methods used for the 
analysis of microbiota: cultivation based techniques detects only a subset of microbes, 
whereas it is possible to detect both cultivable and non-cultivable taxa using next generation 
sequencing. Different regions of oral cavity provide quite different circumstances for 
microbial biofilm formation. Accordingly, the composition of microbiomes varies from 
habitat to habitat. The human oral microbiota is changing during the life, too [39]. We are 
interested in our study for the microbiota of bucca and tongue, because the examined diseases 
develop frequently in firmly and loosely attached mucosa of buccal, gingival and tongue 
surfaces, frequently in middle or old age.  
To compare bacteria of OPMD tissues with bacteria of healthy oral mucosa, we looked for 
information in current literature about oral bacteria in health in childhood, adulthood, and in 
case of an isolated population. Papaioannou et al. described that the soft tissue samples were 
dominated in childhood by streptococci, particularly Streptococcus mitis (18.7%) and 
Streptococcus oralis (9.5%) as well as Streptococcus salivarius (9.5%) [39]. The profiles of 
the tongue dorsum and saliva were characterized by high proportions of Prevotella 
melaninogenica (5.7% and 5.6%, respectively) and S. salivarius (10.9% and 10.7%, 
respectively). Periodontal pathogens were found at very low counts and proportions at all 
sample locations. A. actinomycetemcomitans was presented in all children, albeit in low 
numbers and proportions. Several species showed changes in proportions with age. The 
Actinomyces species showed increased proportions with age at the saliva and tongue 
locations. Streptococci also increased in proportion with age at most sample locations, 
particularly Streptococcus gordonii and Streptococcus sanguinis. T. forsythia, P. gingivalis, T. 
denticola as a group showed a significant increase in proportion with age. P. gingivalis 
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showed a higher dissemination in the oral cavity (i.e. more positive habitats) in the older age 
groups [39]. 
Zaura et al. characterized the oral bacterial communities of healthy adults. They found - as a 
„core microbiome”- fifteen taxa: the genera Streptococcus, Neisseria, Corynebacterium, 
Rothia, Actinomyces, Haemophilus, Prevotella, Fusobacterium, Granulicatella, 
Capnocytophaga, representatives of the Veillonellaceae, Neisseriaceae and Pasteurellaceae 
families, the Bacteroidales order and unclassified Firmicutes. Unclassified Bacteria and an 
additional four taxa were found in two third of samples: genus Porphyromonas, Leptotrichia, 
TM7 genera incertae sedis and Campylobacter. A few sequences dominated each individual 
microbiome. Three of the sequences were found across all samples: two Veillonellaceae 
family members (phylum Firmicutes) and one Fusobacterium genus member (phylum 
Fusobacteria). Fusobacteria mediate coaggregation of microbiota and serve as a structural 
component of both healthy and disease-associated dental plaque. Firmicutes dominated the 
cheek mucosa in two third of volunteers [40]. 
Oral microbiota varies in different human populations, and it is affected by environmental 
factors. Cheek microbiota of isolated amerindians show similar numbers of families to non-
amerindians (30 in Amerindians and 33 in non-Amerindians), but with higher richness of 
genera in non-Amerindians (177) than in Amerindians (51). Amerindians shared only 62% of 
the families and 23% of the genera with non-Amerindians. The Amerindians carried marker 
bacteria that were not reported in previous studies, such as soil bacteria Gp1, and the 
xylanolytic Xylanibacter (Prevotellaceae), as well as Phocoenobacter (Pasteurellaceae), first 
described in a porpoise, in addition to unidentified members of the phyla Bacteroidetes, 
Firmicutes and Proteobacteria [41]. 
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1.3 Evidences for association between bacteria and OSCC 
 
We reviewed the literature as to the potential connections between OSCC and bacteria to 
pinpoint the putative role of distinct bacteria and bacterial symbioses in oral carcinogenesis, 
and to compare the relevant data with our results. 
In a pioneering study, Nagy et al. analysed the biofilm flora present on the surfaces of oral 
squamous cell carcinomas and on the contiguous healthy mucosa [5]. They found a higher 
number of both aerobic and anaerobic colony forming bacteria at the tumour sites than at the 
apparently healthy mucosa. They observed that the frequency of most aerobic species was 
similar at both sites, except Serratia liquefaciens, Klebsiella pneumoniae, Citrobacter 
freundii, betahemolyzing streptococci, and Enterococcus faecalis that were isolated more 
frequently from the biofilm samples obtained from the surfaces of oral carcinomas. Regarding 
anaerobic species, the frequency of peptostreptococci and lactobacilli was comparable at both 
sites, whereas Actinomyces spp., Propionibacterium spp., Clostridium spp., Veillonella spp., 
Fusobacterium spp., Prevotella spp., Porphyromonas spp., and Bacteriodes 
ureolyticus/gracilis was isolated more frequently from the tumor surface than from the control 
mucosal surface [5]. In addition, the fungus Candida albicans was detected in a significant 
fraction of oral carcinomas, but not at control sites [5]. Nagy et al. concluded that the cancer 
lesion itself may predispose patients with oral carcinoma to both local and systemic infections 
[5]. In a follow-up study, they demonstrated that topical antimicrobial treatment of oral 
squamous cell carcinoma lesions effectively reduced the number of biofilm-associated 
bacteria [42].  
In addition to the surface of oral carcinoma, bacteria could be detected inside oral carcinoma 
samples as well. Using in situ hybridization, Hooper et al. found bacteria throughout the 
tumor tissue in surface-decontaminated oral squamous cell carcinoma (OSCC) samples [43]. 
As determined by molecular biological methods, Clavibacter michiganensis, Fusobacterium 
naviforme, Ralstonia insidiosa and Prevotella spp. were enriched in the tumor-derived 
samples. In contrast, control tissue samples were enriched in Granulicatella adiacens, 
Porphyromonas gingivalis, Sphingomonas spp. and Streptococcus mitis/oralis [43]. These 
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data suggested that tumor-associated bacteria may play a role in carcinogenesis, and 
implicated that the acidic and hypoxic microenvironment within neoplasms may favour the 
growth of distinct bacterial species [43]. Others also raised the point that in addition to 
Helicobacter pylori, which was recognized as the causative agent of gastric carcinoma and 
gastric lymphoma in humans, other bacterial species could also play a role in tumorigenesis 
[44, 45]. Schmidt et al. analysed swabs taken from oral cancer lesions and clinically normal 
mucosal surfaces [46]. They observed a reduced abundance of the phyla Firmicutes and 
Actinobacteria, and an increase in proportion of Fusobacteria at the tumor site, indicating that 
the altered surface of oral cancer may affect bacterial adherence and select for bacterial 
populations that elicit inflammatory responses favouring tumor progression [46]. 
Fusobacterium nucleatum, a Gram negative oral pathogen, was recently implicated in colon 
carcinogenesis, too [47-49]. Our observation of an increased prevalence of Fusobacterium 
nucleatum in OPMD samples (see 4.2.3.) is compatible with the data of Schmidt et al. and 
may indicate that Fusobacterium nucleatum is involved also in the initial stage of oral 
carcinogenesis. Bebek et al. compared bacterial communities in head and neck cancer 
(HNCC) and normal mucosa samples [50]. The presence of members of Enterobacteriaceae 
family and the Tenericutes phylum in HNCC correlated with the hypermethylation of a 
cellular gene, MDR1 coding for multidrug resistance protein 1, a drug efflux pump for 
xenobiotic compounds [50]. Silencing of MDR1 by hypermethylation was also observed in 
gastric carcinoma [51]. These data suggested that epigenetic changes induced by bacterial 
infections may facilitate tumorigenesis [50].  
The phylum Tenericutes includes the genera Mycoplasma and Ureaplasma which are 
prevalent in oral samples from STD patients [52]. Furthermore, Mycoplasma species were 
detected in rare cases of oral carcinoma and induced malignant cell transformation in vitro 
[53-56]. However, we did not detect Mycoplasma species in OPMD samples in our study. 
The composition of salivary microbiota may reflect the microbial diversity of the soft tissues 
located in the oral cavity. It was suggested that alterations of tumor cell receptors may 
facilitate the adherence of certain bacteria and the resulting shift of soft tissue microbiota in 
the oral cavity may affect the levels of bacteria in the saliva [57, 58]. Thus, in principle, the 
salivary microbiota could be used as a diagnostic marker of OSCC.  
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Carcinogenic metabolites generated by oral bacteria may play a role in carcinogenesis [59]. It 
was demonstrated that both non-pathogenic Neisseria strains and strains of Streptococcus 
salivarius and Streptococcus intermedius as well as Corynebacterium spp. and Stomatococcus 
spp. are capable to convert ethanol to acetaldehyde, a mutagenic and carcinogenic substance 
[59-61]. Such a mechanism may explain how poor dental status associated with bacterial 
overgrowth may increase oral cancer risk in patients with tooth loss, poor dentition and 
inadequate oral hygiene [60, 62]. Homann et al. demonstrated an increase in salivary 
acetaldehyde production from ethanol in saliva samples of patients with poor dental status 
[62].  
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1.4 Indication and technical basis of our experimental setup 
 
In our experimental setup, we examined the oral microbiome and microbiota of patients 
diagnosed with OPMD. We compared the microbiome and microbiota of healthy and non-
healthy mucosal surfaces. To gain comparable data, we applied two different methods: the 
metagenome sequencing of total DNA purified from tissue specimens and MALDI-TOF MS 
analysis from cultured bacteria. Although Fusobacterium nucleatum was detected by 
metagenomic sequencing in OPMD biopsies, it could not be detected by MALDI-TOF in 
OPMD swab samples cultivated in vitro. To resolve this discrepancy, we made qPCR 
identification of Fusobacterium nucleatum - a bacterium implicated in carcinogenesis [63-68]. 
Finally, we used an experimental murine model to study mucosal lesions elicited  
Helicobacter pylori and compared the histopathological alterations observed to the OPMD 
affected mucosa. 
 
1.4.1 Metagenome sequencing 
We used ion torrent sequencing, a recently developed method, for metagenome analysis. The 
Ion Torrent PGM (Personal Genome Machine) was released at the end of 2010. Ion Torrent 
PGM utilizes a semiconductor sequencing technology, i.e. semiconductor chips. When a 
nucleotide is incorporated into a DNA molecule by DNA polymerase, a proton is released, an 
event recorded by the machine. In consecutive cycles the chip is flooded with one nucleotide 
after another; if there is no incorporation, no signal is recorded [69] For identifying bacterial 
taxons, the most commonly used method is the sequencing of hypervariable regions in 
bacterial 16S rRNA genes. 16S rRNA gene sequencing does not require in vitro cultivation of 
bacteria. Thus, it permits identification of bacterial taxa which do not grow under laboratory 
circumstances, too. Bacterial 16S ribosomal RNA (rRNA) genes contain nine “hypervariable 
regions” (V1 – V9) that demonstrate considerable sequence diversity among different 
bacteria. Most important regions are V1,V2,V3, and V6 [70,71].  
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1.4.2 MALDI-TOF MS 
 
In contrast to metagenome sequencing, in vitro cultivation of bacteria is an important step 
before identification of bacteria by mass spectrometry. Thus, in the case of bacterial or fungal 
identification with MALDI-TOF MS (Matrix Assisted Laser Desorption Ionization Time Of 
Flight Mass Spectometry), a microbial colony is analyzed, or in some cases, direct blood 
culture material, urine, cerebrospinal fluid (CSF), or protein extract is used. Upon drying, the 
clinical material and the matrix (HCCA, 2,5-DHB, 3- HPA, etc.) cocrystallize and form a 
solid deposit of sample embedded into the matrix. This sample-matrix crystal, now present on 
the surface of the metal plate, is irradiated by using a UV laser beam (usually, an N2 laser 
beam with a wavelength of 337 nm is utilized in commercial instruments). Specimen with 
matrix will be together softly ionised to avoid degradation. Proteins within the clinical 
specimen are analyzed by the mass analyzer to reveal characteristic information about the 
composition of the sample in the context of a spectrum of mass-to-charge (m/z) ratios. The 
m/z ratios that are generated and considered when formulating a microbial identification are 
ribosomal proteins that are unique to their respective bacterial groups or species. In linear 
TOF, ions generated from the source are accelerated into the flight tube and enter a field-free 
region where they are separated according to their velocities (and size), before hitting the 
detector located at the other end of the tube. A reflectron is a focusing element at the end of 
the TOF instrument that changes the direction of ion travel. A voltage is applied to these 
lenses and causes a change in the trajectory of that ion. Ions with a higher kinetic energy will 
penetrate the reflectron deeper than those with a lower kinetic energy [72]. 
 
  
 19  
 
2 Objectives 
 
The main objective was to investigate the microbiome and microbiota of the OPMD with 
unknown etiology. 
 
 
Aims: 
 
1. To analyse and compare the microbiome of the clinically healthy and OPMD-
affected oral mucosal tissues by metagenome sequencing technique. 
 
We hypothesized, that the microbiome of clinically healthy and OPMD-affected 
tissues are different, i.e. pathogenic bacteria are overrepresented in the mucosal 
samples of OPMD affected tissues. 
 
2. To analyse and compare the microbiota of the healthy and OPMD oral mucosal 
tissues by MALDI-TOF MS analysis of cultured bacteria.  
 
We hypothesized, that the data obtained by MALDI-TOF MS will be comparable 
to the results of metagenome sequencing.  
 
3.  To verify inflammatory histopathological changes after the mucosal infiltration by 
H. pylori, a bacterium of known tumorigenic potential, in an in vivo murine 
experimental model. 
 
We hypothesized, that if OPMDs are caused or triggered by bacteria, the 
histopathological changes in OPMD lesions may be similar to the changes in 
H.pylory induced gastric mucosal inflammation and cancer. 
 
4. To compare our results with existing research.  
 
We hypothesized, that the bacterial alterations in OPMD lesions will be 
comparable those suggested by the current literature for OSCC. 
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3 Materials and Methods 
 
3.1 Patient selection 
 
Potential participants were interviewed by the clinical coordinators at the University of 
Szeged, Faculty of Dentistry. Every potential participant was informed about the ethical 
permission of the study and received both written and oral information on the goals and 
procedures of this study. The initial participants were selected by volunteering activity and the 
detailed questionnaire on family anamnesis, chronic diseases, medication-, alcohol-, tobacco- 
and drug consumption, oral hygiene, and sexual habits was filled out by the volunteers. 
Eligibility was determined based on the results of this questionnaire. Female and male 
subjects over 18 years of age were eligible for the study, provided that they were able to 
provide signed and dated informed consent and if they did not meet any of the exclusion 
criteria. As for the patient group, an established diagnosis of OPMD was also a requirement. 
Clinical diagnosis was established after clinical examination (inspection, palpation) 
performed by oral medicine specialist, followed by differentialdiagnostical evaluation of 
symptoms and anamnestic data. On suspicion of OPMD, volunteers were included into our 
study and specimens were taken for pathological and microbiological examination (see 
below). From that examined group we selected patients with the clinical and pathological 
diagnosis of OLP, and patients with the clinical diagnosis of verrucous leukoplakia supported 
by pathological diagnosis as well. The exclusion criteria included vital signs outside the 
acceptable range at the screening visit (i.e., blood pressure > 140/90 mmHg, oral temperature 
> 37 °C, heart rate > 100/min), pregnancy, the potential subject being a sex worker, topical 
antibiotic treatment up to 7 days before the screening visit, and the use of the following drugs 
within 2 months before the screening visit: systemic antibiotics, corticosteroids, cytokines, 
methotrexate or immunosuppressive cytotoxic agents, or large doses of commercial probiotics 
(≥ 108 CFU mL−1 organisms per day). No patients were on specific diet, nor on antibiotic 
therapy in the previous 6 months. The clinical characteristics and brief medical history of the 
patient group is given in Table 2. The study protocol conformed to the Declaration of Helsinki 
in all respects and was approved by the Institutional Ethics Committee of the University of 
Szeged (No. 3161).  
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Table 2 Brief medical history of patients 
patient 1 2 3 4 5 6 7 
gender ♂ ♂ ♀/2 PM ♀/2 PM ♂ ♂ ♀/1 PM 
age 60 73 62 57 85 54 77 
clinical 
diagnosis 
leukoplakia 
verrucosa 
labii 
leukoplakia 
proliferativa 
verrucosa  
gingivae 
lichen 
reticularis et 
atrophicans 
buccae et 
linguae 
lichen 
reticularis et 
plaque 
buccae 
lichen 
reticularis 
buccae 
lichen 
atrophica
ns 
buccae 
lichen 
reticularis et 
atrophicans 
buccae et 
gingivae 
pathological 
diagnosis 
acanthosis 
hyper-
parakeratosis 
lymphoid 
infiltr. 
neutrophil 
exocytosis 
candidosis 
epithelial 
hyperplasia 
hyperkeratosis 
chr. lichenoid 
inflam. 
lichen 
chr. lichen 
simplex 
lichen lichen 
systemic 
diseases 
HT, 
onychomyco
sis,  MI, cGa, 
cDu , IHD 
HT, hChol, 
hTG 
no HT 
HT, 
hypothyr, 
h.uricemia 
no 
HT, DM, RA, 
h.uricemia, 
hyperthyr., 
hChol 
allergy no no no no 
medicine 
allergy 
no no 
years of 
smoking 
10 0 0 0 20 20 2,5 
alcohol 
consumption 
/day 
no 2-3 unit (wine) no no 2 unit (wine) no no 
frequency of  
tooth- 
brushing 
every week 
many times a 
day 
many times a 
day 
many times a 
day 
once a day 
many 
times a 
day 
many times a 
day 
use of oral 
rinse 
no 
many times a 
day, changed 
no 
Listerine/ 
Corsodyl 
no 
Listerine
/ Meridol 
Listerine 
sexual activity 
none in the 
past 4 yrs 
active active active active active active 
oral sexual 
activity 
no no no yes no yes no 
 
Supplementary data: no patients were on specific diet, or on antibiotic therapy in the last 6 
month. Current medication of patients: 1) Asactal, Concor, Pantoprazol, Roxera, Apranax, 
Tritace. 2) Lipidil, Xeter, Chinotal, Nortivan, Agen, Aspirin Protect 3)Ø 4) Betaserc, 
Nootropil, Prenessa, Frontin 5) Tiroxin, Milurit, Warfarin 6) Ø 7) L-Thyroxin, Meloxep, 
Rosuvastatin, Glucobay, Milurit, Talliton, Frontin, Tramadol, Moxogamma, Metoprolol, 
Enalapril, Meloxep, Apo-Famotidin, chrom, vitamin-C, vitamin-D, Mg-B6, kurkuma 
Abbreviations: PM: postmenopausal; /1/2: parity; HT: hypertension; MI: Myocardial infarct; 
cGa: chronic gastritis; cDu: chronic duodenitis; IHD: ischemic heart disease; hChol: 
hypercholesterinaemia; hTG: Hypertrigliceridaemia, DM: diabetes mellitus; RA: rheumatoid 
arthritis; hypothr: hypothryreosis, hyperthr: hyperthyreosis, h.uricemia: hyperuricemia 
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3.2 Metagenome sequencing 
 
3.2.1 Tissue sample collection for metagenome sequencing and histopathological 
assessment 
 
As a classical method for tissue sample collection from mucosal lesions in the oral cavity, we 
used punch biopsy. The biopsy was made with punches 4 mm in diameter. We collected 2 
identical samples from the intralesional area: one sample was taken for hematoxylin-eosin 
(HE) staining, and an additional sample for metagenome sequencing. Additionally, we also 
collected a third, control specimen from the ipsilateral healthy mucosa for metagenome 
sequencing. The specimens contained the mucosa, and submucosal connective tissue. Samples 
for metagenome sequencing were collected in Eppendorf tubes filled with 20 mM potassium 
phosphate buffer (pH 7.0), and stored at −20 °C. Tissue samples for HE staining were fixed in 
formaldehyde solution, and sent for histopathological assessment.  
 
3.2.2 Metagenomic DNA isolation 
 
Total DNA was isolated from patient samples as described previously, with minor 
modifications [73]. Briefly, samples (600 μL) were suspended in 650 μL of extraction buffer 
(100 mM TrisCl, pH 8.0, 100 mM EDTA, pH 8.0, 1.5 M NaCl, 100 mM sodium phosphate, 
pH 8.0, 1% CTAB) 3.5 μL proteinase K (20.2 mg mL−1) and incubated horizontally at 37 °C 
for 45 min, next 80 μL of 20% SDS was added and mixed by inversion for several times with 
further incubation at 60 °C for 1 h. The sample in each tube was mixed thoroughly every 15 
min. The particles were collected by centrifugation (17,000 g) for 5 min. The supernatant was 
transferred into clean tubes and was mixed with equal quantity of phenol chloroform and 
isoamyl alcohol (25:24:1) and extracted three times. DNA was precipitated with 0.7 volume 
isopropanol, the pellet was washed with 70% ethanol. Crude DNA pellets were dried and 
dissolved in 50 μL of TE buffer (10 mM Tris-HCl, 1 mM sodium EDTA, pH 8.0). 
Metagenomic DNA was quantified using Qubit® 2.0 Fluorometer. Half of total metagenomic 
DNA from the healthy and lesion samples were pooled and stored at−20 °C for sequencing. 
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3.2.3 Library preparation and sequencing 
 
Ion Torrent PGM Fragment libraries of 200 nt were generated according to the appropriate 
protocols (Ion Torrent PGM, Life Tech, USA). 1 μg pooled metagenomic DNA from each 
sample was used for library preparation for each sample. DNA shearing and end-repair was 
achieved by Ion Xpress™ Plus Fragment Library Kit, and DNA Purification was carried out 
by PureLink PCR Purification Kit (Thermo Fisher Scientific, MA). Adapter ligation and nick 
translation were performed by Ion Shear Plus Reagents Kit (Thermo Fisher Scientific, MA). 
Size selection was performed in 2% agarose gel to enrich the 300–350 nt fragments then 
library amplification was achieved by using Platinum® PCR SuperMix (Thermo Fisher 
Scientific, MA). ION Library TaqMan qPCR was used for quantitation and Ion Xpress 
Template 200 ePCR kit was used for the emulsion PCR. Sequencing was performed on Ion 
Torrent Personal Genome Machine™ using Ion 318 chip. Ion Torrent Personal Genome 
Machine™ sequencing resulted 872,798 sequence reads for sample 1 (control) with an 
average read length of 219 ± 71 bases and 644,200 sequence reads for sample 2 (diseased) 
with an average read length of 220 ± 72 bases. 
 
3.2.4 Quality assurance 
 
The MG-RAST software performs a QC (quality control) and an automatic normalization of 
the FASTQ sequence. For the taxonomical analyses, maximum e-value cut-off of 10−15, 
minimum percent identity cut-off 90% and minimum alignment length cut-off 40 nt settings 
were applied. The overall community composition was determined using the M5nr database. 
Hits for the eukaryotic data were removed and relative abundance of the bacterial data was 
calculated. 
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3.3 MALDI-TOF MS analysis 
 
3.3.1 Swab sample collection for microbiological culture and identification by MALDI-
TOF MS 
 
We used cotton swabs for collecting bacterial samples. Two individual samples were taken 
from each patient, one from the surface of the lesion, and another one from the ipsilateral 
healthy (non-involved) mucosa. The swabs were rolled 4 times over the chosen areas. Then 
the swabs were placed in anaerobic transport medium (AnaerobeSystems, CA) and sent 
immediately to the Institute of Clinical Microbiology, University of Szeged, for bacterial 
cultivation and identification. 
 
3.3.2 MALDI-TOF MS analysis 
 
The cells on the cotton swabs in anaerobic transport media were suspended in 1 mL Brain-
Heart Infusion (BHI) broth which were diluted in BHI to 10
-2
 and 10
-4
-fold and selective 
cultivations were done on chocolate agar, Sabouraud agar for fungi (37 °C aerobically 24 h), 
anaerobic Columbia agar (Columbia base supplemented with 2.5 % sheep blood, 1.25 % 
laked sheep blood, 30 mg L
-1
 cysteine and 1 mg L
-1
 Vitamin K1), Kanamycin laked Blood 
agar and Bacteroides Bile Esculin agar (37 °C anaerobically 48-72 h). The cultivated isolated 
colonies with different morphologies were recorded and subcultured on Chocolate agar or 
Anaerobic Columbia agar at 37 °C for 24 h in aerobiosis or 48 h in anaerobiosis, respectively. 
The cultivated strains were identified to species level by MALDI-TOF MS analysis 
(microflex, Bruker Daltonics, Bremen, Germany) using the Real Time Classification 3.1 
software and database. Species identification was accepted if the logScores were >2 or genus 
identification if the logScores were between 1.7 and 2 [74]. 
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3.4 Fusobacterium nucleatum qPCR 
 
3.4.1 Fusobacterium nucleatum qPCR process 
 
DNA templates for qPCR were prepared from the undiluted BHI suspensions of the oral 
swabs (collected for MALDI-TOF MS analysis) by the QiAmp Stool Mini DNA Kit (Qiagen, 
Germany) as recommended by the supplier. Subsequent quantitative RT-PCRs for 
Fusobacterium nucleatum were done in StepOne RT-PCR instrument (Invitrogen, CA) using 
5 μL Brilliant II master mix (Agilent), primers FnucF CTTAGGAATGAGACAGAGATG 
and FnucR TGATGGTAACATACGAAAGG 0.2 μL (35 pmole/μL) each, 1 μL of template 
sample and the following cycling conditions: starting denaturation and hot start activation 95 
°C 10 min, 95 °C 15 s, 56 °C 15 s and 72 °C 30 s, 40×; and a melting curve from 72 °C to 95 
°C [75] CFUs were calculated comparing the means of threshold cycles to ones of a F. 
nucleatum 10-fold serial dilution samples prepared with the same kit. 
 
3.4.2 Data analysis 
 
For the comparison of the numerical data, the Mann-Whitney U test was used in SPSS 21.0 
(IBM, NY). 
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3.5 Histological examinations 
 
3.5.1 Histopathological assessment of the tissue samples collected from OPMD affected 
mucosa  
 
Tissue samples for HE staining were fixed in 4% buffered formaldehyde, and were sent for 
histopathological assessment to the Department of Pathology, University of Szeged. HE 
stained sections were examined with light microscope. Pathological dataset (Table 3) included 
the absence or presence, together with severity of hyperkeratosis, hyperplasia, reactive atypia, 
dysplasia, and lichenoid infiltrate [76]. 
 
3.5.2 Examination of mucosal lesions caused by Helicobacter pylori in a murine model 
 
3.5.2.1 Infection 
Specific-pathogen-free six to eight-week-old female Balb/c mice were obtained from Charles 
River (Germany). Infections with H. pylori SS1 strain were established three times over a 
five-day period by administration via feeding needle of 100 μL bacterium suspension in BHIB 
(109 CFU/mL). Negative control mice remained uninfected. One week later, some animals 
were sacrificed to verify the success of infection by PCR.  
 
3.5.2.2 Histology 
Gastric samples were fixed in 4% buffered formaldehyde for 24 hours, embedded in paraffin 
blockers and cut into 4 μm serial sections (Leica RM2245). Each sample was autostained 
(Leica ST5020) by routine Giemsa for highlighting H. pylori bacteria. Slides were archived 
by virtual microscopy using slide scanner (3DHistech, Budapest, Hungary) [77]. 
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4 Results 
 
4.1 Histopathological alterations 
 
4.1.1 Histopathological changes in OPMD tissues 
 
 
Table 3 The histopathological characteristics of the biopsies 
patient 1 2 3 4 5 6 7 
OPMD + + + + + + + 
hyperkeratosis + ++ +++ +++ + +++ +++ 
hyperplasia +++ ++ + +++ - +++ +++ 
reactive atypia - + - + - + + 
dysplasia - + - - - - - 
lichenoid infiltrate + +++ ++ +++ +++ +++ ++ 
MT - - - - - - - 
 
Abbreviations: (− no, + mild, ++ moderate, +++ severe; OPMD: oral potentially malignant 
disorder; MT: malignant transformation) 
 
Sample selection was based on the histological analysis of oral potentially malignant 
disorders (OPMDs). Figure 1 shows representative pictures of the OPMD tissue samples with 
marked hyperkeratosis, acanthosis and lichenoid infiltration. The major histopathological 
characteristics of the OPMD lesions are summarized in Table 3. Severe hyperkeratosis could 
be observed in 4 samples, whereas moderate or mild hyperkeratosis was detected in 1 and 2 
OPMD biopsies, respectively. The degree of hyperplasia was scored as severe in 4 samples, 
and it was moderate, mild or absent in 1 sample, each. Reactive atypia was recorded in 4 
cases, and it was absent in 3 samples. Dysplasia was observed in a single sample only. 
Lichenoid infiltrate by lymphoid cells was documented in each biopsy sample (severe: 4 
cases; moderate: 2 cases; mild. 1 case). In contrast, there was no sign of malignant 
transformation in either sample. 
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Fig. 1 Representative pictures from OPMD tissue samples with marked hyperorthokeratosis 
(a, b – HyKer), acanthosis and band-like lymho-plasmocytic subepithelial lichenoid infiltrate 
(a, d – LI). Occasionally there was a marked verrucous hyperplasia with elongated dermal 
papillae (rete pegs) (c – DP). Note the regenerative basal cell changes (b – RA/regenerative 
atypia/), in contrast to mild dysplasia (d – DY) with focal acantholysis and civatte bodies 
/HE; OM 112×/ 
 
 
4.1.2 Histopathological changes in Helicobacter pylori infected gastric mucosa 
 
Histopathological analyses verified the bacterial colonization and H. pylori induced 
inflammation of gastric mucosa in a murine in vivo experimental model. H. pylori foveolar 
colonization in gastric fundus and the intra-epithelial mononuclear lymphoid elements of the 
mucosa shows the infection and the inflammational reaction of the gastric mucosa, but the 
distribution of lymphocites is different, as in OPMD samples [77]. 
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Fig. 2 Long-term H. pylori infection of positive control (infected, untreated) mice. Giemsa-
stained gastric specimens five weeks after infection. Arrows show H. pylori foveolar 
colonization in gastric fundus sample (Giemsa staining; OM 200×), and the intra-epithelial 
mononuclear lymphoid elements of the mucosa are noted (circles)[77] 
 
We did not detect lichenoid infiltration of lymphoid cells, in contrast to the histological 
findings described in the case of lichen, or in several cases of verrucous leukoplakias in 
humans [78]. 
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4.2 Analysis of microbiome/microbiota in biopsy and swab samples from 
OPMD lesions and healthy oral mucosa 
 
4.2.1 Microbiome analysis by metagenome sequencing 
 
First, we determined the ratio of bacterial DNA in our sample. As punch biopsy samples 
contain a high amount of human tissue, this step helped us to define the limitation of the 
study. In healthy oral mucosa samples, 6.78% of the sequence reads were annotated to the 
domain Bacteria. The ratio of bacterial sequences was similar (6.87%) in the pooled OPMD 
DNA samples (Fig. 3). 
Fig. 3 Distribution of taxonomic domains in OPMD biopsy and healthy oral mucosa samples. 
There were no significant differences in the distributions of taxonomic domains between the 
healthy tissue and the OPMD lesion. 6.78% of bacterial domains were detected in healthy 
area compared 6.87% of bacterial domains in white lesions of oral mucosa  
Metagenome sequencing revealed that the bacterial diversity in the OPMD biopsies was 
higher compared to the healthy oral mucosa. Within the Bacteria domain the phyla 
Firmicutes, Fusobacteria, Proteobacteria, Actinobacteria, Bacteroidetes phyla were present 
in the healthy oral mucosa. In the OPMD biopsies the same phyla, i.e. Firmicutes, 
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Fusobacteria, Proteobacteria, Actinobacteria and Bacteroidetes were identified in 
descending order of relative abundance; however, two additional phyla, Fibrobacteres and 
Spirochaetes were observed, too (Fig. 4a). On the species level, 18 bacterial species were 
detected in the healthy tissue, 35 species were unique for the OPMD lesions and 8 bacterial 
species were detected both in healthy oral mucosa and the OPMD biopsy samples (Fig. 4b). 
Fig. 4 Bacterial diversity in OPMD biopsy and healthy oral mucosa samples. a Metagenome 
sequencing revealed that the bacterial diversity in the OPMD biopsies was higher compared 
to the healthy oral mucosa. Within the Bacteria domain Firmicutes, Fusobacteria, 
Proteobacteria, Actinobacteria, Bacteroidetes phyla were present in the healthy oral mucosa. 
In the OPMD biopsies the same phyla were identified in descending order of relative 
abundance; however, two additional phyla, Fibrobacteres and Spirochaetes were observed, 
too. b Metagenome sequencing detected 18 different bacterial species in healthy tissue and 43 
species in the OPMD lesion, whereas 8 bacterial species were detected in both samples 
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Analysis of bacterial species by metagenome sequencing showed a marked, 2.38 fold increase 
in bacterial diversity in the OPMD tissue samples compared to healthy mucosa (Fig. 5, Table 
4). 
 
 
 
 
 
Fig.5 Comparison of the detected bacterial species Metagenome sequencing detected 18 
different bacterial species in healthy tissue and 43 species in the OPMD lesion  
 
Based on the data of metagenome sequencing, the relative abundance of Streptococcus sp. did 
not show a significant difference between the healthy tissue and the OPMD lesions: it was 
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61.82% in healthy tissue and 58.62% in OPMD, respectively (Fig. 6a) However, the relative 
abundance of Streptococcus mitis was found to be dramatically decreased in OPMD: it was 
only 18.62%, compared to 32.73% in the healthy tissue (Fig. 6b). Moreover, examining all 
Streptococcus species their prevalence in the OPMD lesions was found to be more diverse 
compared to the healthy tissue (Table 4).  
Fig. 6 Relative abundance of Streptococci in the mucosal lesion  
a The ratio of Streptococci to all oral bacteria was not significantly different in the healthy 
tissue compared to the OPMD lesion.  
b The relative abundance of Streptococcus mitis dramatically decreased in OPMD, as 
compared to the healthy tissue 
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Table 4 Comparison of bacterial diversity in the healthy mucosa and the OPMD lesion 
Species  Phylum Healthy OPMD 
Streptococcus mitis Firmicutes 32,73% 18,62% 
Streptococcus pneumoniae Firmicutes 25,45% 13,79% 
Gemella haemolysans Firmicutes 7,27% 1,38% 
Rothia dentocariosa Actinobacteria 3,64% 0,021 
Fusobacterium nucleatum Fusobacteria 3,64% 5,52% 
Actinomyces urogenitalis Actinobacteria 1,82% 0,69% 
Streptococcus oralis Firmicutes 1,82% 4,14% 
Haemophilus influenza Proteobacteria 1,82% 1,38% 
Fusobacterium sp. 3_1_36A2 Fusobacteria 3,64% 0 
Fusobacterium sp. 4_1_13 Fusobacteria 3,64% 0 
Porphyromonas gingivalis Bacteroidetes 1,82% 0 
Prevotella bergensis Bacteroidetes 1,82% 0 
Gemella morbillorum Firmicutes 1,82% 0 
Streptococcus infantis Firmicutes 1,82% 0 
Neisseria meningitides Proteobacteria 1,82% 0 
Neisseria subflava Proteobacteria 1,82% 0 
Enhydrobacter aerosaccus Proteobacteria 1,82% 0 
Psychrobacter sp. PRwf-1 Proteobacteria 1,82% 0 
Streptococcus parasanguinis Firmicutes 0 4,83% 
Fibrobacter succinogenes Fibrobacteres 0 4,14% 
Streptococcus sp. M143 Firmicutes 0 4,14% 
Campylobacter concisus Proteobacteria 0 4,14% 
Streptococcus sanguinis Firmicutes 0 2,76% 
Streptococcus sp. M334 Firmicutes 0 2,76% 
Prevotella melaninogenica Bacteroidetes 0 2,07% 
Capnocytophaga ochracea Bacteroidetes 0 2,07% 
Streptococcus vestibularis Firmicutes 0 2,07% 
Veillonella parvula Firmicutes 0 2,07% 
Rothia mucilaginosa Actinobacteria 0 2,07% 
Corynebacterium efficiens Actinobacteria 0 1,38% 
Corynebacterium matruchotii Actinobacteria 0 1,38% 
Granulicatella adiacens Firmicutes 0 1,38% 
Streptococcus gordonii Firmicutes 0 1,38% 
Streptococcus salivarius Firmicutes 0 1,38% 
Leptotrichia buccalis Fusobacteria 0 1,38% 
Actinomyces sp. oral taxon 171 Actinobacteria 0 0,69% 
Thermomonospora curvata Actinobacteria 0 0,69% 
Capnocytophaga gingivalis Bacteroidetes 0 0,69% 
Gemella morbillorum Firmicutes 0 0,69% 
Streptococcus pyogenes Firmicutes 0 0,69% 
Streptococcus sp. C300 Firmicutes 0 0,69% 
Streptococcus sp. oral taxon 071 Firmicutes 0 0,69% 
Streptococcus thermophiles Firmicutes 0 0,69% 
Parvimonas micra Firmicutes 0 0,69% 
Eubacterium saburreum Firmicutes 0 0,69% 
Veillonella sp. 3_1_44 Firmicutes 0 0,69% 
Veillonella sp. oral taxon 158 Firmicutes 0 0,69% 
Fusobacterium sp. 1_1_41FAA Fusobacteria 0 0,69% 
Fusobacterium sp. 3_1_27 Fusobacteria 0 0,69% 
Fusobacterium sp. 7_1 Fusobacteria 0 0,69% 
Lautropia mirabilis Proteobacteria 0 0,69% 
Delftia acidovorans Proteobacteria 0 0,69% 
Simonsiella muelleri Bacteroidetes 0 0,69% 
Treponema vincentii Spirochaetes 0 0,69% 
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According to the results of metagenome sequencing, the relative abundance of Fusobacterium 
nucleatum was higher in the OPMD lesions (5.52%), compared to the healthy tissue (3.64%) 
(Fig. 7).  
Fig. 7 Fusobacterium nucleatum in OPMD and healthy oral mucosa biopsies  
The ratio of Fusobacterium nucleatum was markedly increased in the OPMD lesions, as 
compared to the healthy tissue detected by metagenome sequencing 
 
 
In OPMD, the relative abundance of Fusobacterium nucleatum and Streptococcus oralis was 
5.52% and 4.14%, respectively. In healthy mucosa, the corresponding data were lower (3.64% 
versus 1.82%). The abundances of the species Gemella haemolysans (1.38%), and the above 
mentioned S.mitis (18.62%) decreased markedly in OPMD as compared to the healthy tissue 
(7.27% and 32.73%) (Table 4). There where 35 different bacterial species detected in the 
OPMD lesions which were not represented in the healthy tissue, e.g., Streptococcus 
parasanguinis, Fibrobacter succinogenes, Campylobacter concisus, Streptococcus sanguinis, 
Rothia mucilaginosa, Prevotella melaninogenica, Capnocytophaga ochracea, Streptococcus 
vestibularis, Veillonella parvula, Corynebacterium efficiens, Corynebacterium matruchotii, 
Granulicatella adiacens, Streptococcus gordonii, Streptococcus salivarius, Leptotrichia 
buccalis, Thermomonospora curvata, Capnocytophaga gingivalis, Streptococcus pyogenes, 
Streptococcus thermophiles, Parvimonas micra, Eubacterium saburreum, Lautropia 
mirabilis, Delftia acidovorans, Simonsiella muelleri, Treponema vincentii, etc., in descending 
order of the abundance. 
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4.2.2 Analysis of microbiota by MALDI-TOF MS 
 
Compared to metagenome sequencing data, the MALDI-TOF MS based method indicated 
markedly different results. We detected 41 bacterial species in healthy tissue and 36 species in 
the OPMD lesions (Fig. 8). There were 25 overlapping bacterial species in healthy tissue 
samples and OPMD lesion. Although the MALDI-TOF MS results showed a similar – 
decreasing- tendency regarding the presence of Streptococcus species in OPMD lesions, we 
did not find the expected markedly increasing tendency as to the presence of Fusobacterium 
nucleatum. 
These results highlight the limitations of metagenome sequencing and MALDI-TOF MS 
methods. While metagenome sequencing is representative of the information content of all 
DNA present in the sample, MALDI-TOF MS only provides information on the presence of 
bacteria that grow well under the given culture conditions. 
 
 
 
 
Fig. 8 MALDI-TOF MS analysis detected 41 different bacterial species in healthy tissue and 
36 species in the lesion. 25 bacterial species were detected in both samples 
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4.2.3 Quantitation of Fusobacterium nucleatum in oral swab samples by qPCR 
 
As F. nucleatum was implicated in carcinogenesis in several cancers [63-67], we verified the 
results of metagenome sequencing and MALDI-TOF MS by F. nucleatum-specific qPCR. As 
Fig. 9 shows, the number of bacteria (CFUs) was significantly higher (P < 0.0001) in oral 
swab samples taken from the surface of OPMD lesions than in those from the healthy mucosa. 
This difference is remarkable, even when one considers the high inter-individual variability of 
the samples. 
Fig. 9 Fusobacterium nucleatum-specific qPCR of healthy oral mucosa and the OPMD  
samples. In vitro bacterial cultures of oral swab samples fromhealthy mucosa and OPMD 
lesions were assayed using Fusobacterium nucleatum-specific qPCR. Colony forming units 
(CFUs) were calculated by comparing the means of thresold cycles to those of serial dilution 
samples of control F. nucleatum cultures. 
OPMD showed a significantly higher colonization by F. nucleatum compared to healthy 
mucosa  
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5 Discussion 
 
It was suggested that OPMD (oral potentially malignant disorders) and oral cancer frequently 
associated with alcohol and tobacco consumption, and affected mainly males in their fifties 
[2]. Other epidemiological data indicated, however, that a distinct subgroup of oral cancer 
patients aged 45 years and under showed no significant exposure to the traditional risk factors 
tobacco and alcohol [4]. Accordingly, we included a wide range of patients in our study, 
without strict limitations on age or sex. Because bacteria were implicated in oral 
carcinogenesis (reviewed by Hettmann et al., 2016 [13]), we compared the microbiome and 
microbiota of healthy mucosa and OPMD tissues of oral cavity.  
Regarding the putative role of distinct oral bacteria in tumorigenesis, the association of 
Fusobacterium nucleatum with colorectal carcinoma and oral carcinoma was documented [67, 
68]. Moreover, it was suggested that a distinct subspecies of F. nucleatum, such as F. 
nucleatum subsp. polymorphum may play an etiopathogenetic role in oral carcinogenesis [65].  
A study also described the presence of F. nucleatum in desquamative gingivitis [79]. Our 
finding that F. nucleatum is present in OPMD may be exploited to develop a novel 
therapeutic strategy of distinct oral disorders such as oral lichen planus. In addition, one may 
speculate that a targeted antibiotic therapy could be beneficial in preventing the development 
of oral cancer in a subset of OPMD patients.  
We observed that the relative abundance of Streptococcus mitis decreased dramatically in the 
pathological niche of OPMD. Since Streptococcus species are characteristic components of 
the oral flora, the quantitative analysis of these bacteria is indispensable for the understanding 
of pathological processes. Streptococci comprise of a wide variety of bacterial species that 
interact with other members of the oral microbiome. It was suggested that S. mitis is involved 
in the maintenance of a healthy oral flora by affecting adhesion and biofilm formation by 
periodontal pathogens to [80-82]. 
Therefore, it is an interesting and important finding that the relative abundance of S. mitis in 
the OPMD lesions decreased to nearly the half of the healthy area. This observation may 
possibly be exploited for therapeutic purposes: similarly to the reconditioning of vaginal 
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Lactobacillus balance [83], the restitution of S. mitis niche in OPMD could also have 
beneficial effects [84].  
In comparison with earlier results [13], Actinomyces spp., Veilonella spp., Fusobacterium 
spp., Prevotella spp., Streptococcus spp., and Corynebacterium spp. were represented in our 
OPMD samples, similarly to OSCC with mentioned putative role in carcinogenesis. Gemella 
spp. as a suggested spp with putative role in OSCC carcinogenesis was found also in our 
OPMD samples, but was represented in higher rate in healthy mucosa. We did not find in our 
OPMD samples bacteria characteristic for OSCC, such as Serratia liquefaciens, Klebsiella 
pneumoniae, Citrobacter freundii, Enterococcus faecalis, Propionibacterium spp., 
Clostridium spp., Porphyromonas spp., Bacteroides ureolyticus/gracilis, Clavibacter 
michigenensis, Ralstonia insidosa, Peptostreptococcus stomatis, Johnsonella ignova, 
Enterobacteriaceae (family), Tenericutes (phylum), Stomatoccus spp. 
Similarly to metagenome sequencing, a moderate change of normal flora bacteria 
Streptococci was detected also with MALDI-TOF MS. However, in contrast to the 
sequencing data, overrepresentation of Fusobacterium nucleatum was not detected in the 
OPMD samples with MALDI-TOF MS. Detection of Fusobacterium nucleatum by qPCR in 
the very same samples that were used for MALDI-TOF analysis revealed that the sensitivity 
of culturing followed by MALDI-TOF MS examination for F. nucleatum was in our case low. 
The results obtained from the different methods used indicated that metagenome sequencing 
yielded a more diverse bacterial community in OPMD than MALDI-TOF MS. It should not 
be forgotten that while metagenome sequencing allows the identification almost all 
represented DNA sequences, MALDI-TOF MS builds on the classic methodology of 
microbiological culturing since MALDI-TOF MS uses samples which were cultured from the 
oral swabs. One may also argue that swab samples used for culturing were taken from the 
surface of the mucosa of OPMD lesions. Thus, they did not represent the microbiota of deeper 
mucosal layers. Perhaps, in a follow-up study, it would be more efficient to use brush biopsy 
to sample altered mucosal surfaces for culturing before MALDI-TOF MS. Differences 
between results of metagenome sequencing and MALDI-TOF MS analysis reveals, we should 
assess the limitations of different methods to choose the appropriate experimental setup in 
follow-up study.  
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Taken together, we presented evidence for the alteration of microbiome and microbiota of 
OPMD patients. We detected an increased bacterial diversity by metagenome sequencing in 
the OPMD lesions compared to the healthy oral mucosa. In addition, decreased relative 
abundance of S. mitis and an increased relative abundance of F. nucleatum may play a role in 
the transition of OPMDs to oral cancer. 
If there is an association between a bacterial species and oral carcinogenesis, it is important to 
know, what kind of mechanism leads to malignant transformation. One possibility is that 
epigenetic alterations facilitate the development of OPMDs or induce dysplastic changes [50, 
51]. Production of mutagenic metabolites may also result in genotypic and phenotypic 
alterations [21, 59-62]. In addition, direct effect of bacterial antigenes on cell surfaces [85, 
86], intracellular invasion of bacteria in mucosal cells [21, 87] or the effect of mucosal 
inflammation caused by immunresponse of immune cells against bacteria [88, 89] may also 
contribute to tumorigenesis. Histopathologically, we can examine the presence of mucosal 
histologycal and cellular alterations, accumulation of inflammatory cells and bacterial 
invasion. 
In our experimental setup we examined lichen planus (OLP) and proliferative verrucous 
leukoplakia (PVL), two etiologically different diseases. In case of OLP, there are conflicting 
data regarding the role of bacterial infection. [30-37] In our clinical experience the level and 
duration of CD8+ T cell mediated lichenoid „interface type” autoimmun inflammation is in 
correlation with the development of dysplastic changes [90-92]. In case of OLP it is also 
known that if the mucosal surface of OLP is infected with Candida albicans, some pathogen 
bacteria or viruses, the inflammation is usually more severe, and the lichen tends to be 
atrophic, erosive, or ulcerative clinical type. After the eradication of pathogens, the 
inflammation and clinical type of OLP will be again milder [93, 94].  
To compare the histopathological inflammational signs of our OPMD tissue samples, we 
checked a known mucosal infection wich increase the risk of malignant transformation (Fig. 
2) - inflamed gastric mucosa of Helicobacter pylori infected mice [95]. In the murine model, 
there were numerous of mononuclear lymphoid elements in the inflamed mucosa. 
However we could not find lichenoid infiltration of lymphoid cells described in case of 
lichen, or in several cases of verrucous leukoplakias [78]. 
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In OPMD cases, some inducing or initiator factor is needed for transition to the cancerous 
malformation. This factor can also be an inflammatory process. The role of H. pylori in 
various tumorous degeneration as well as in OSCC has been demonstrated [96, 97]. In OPMD 
there are both supporting as well as negative evidences for a connection with H. pylori 
infection [20, 31-35]. In our animal model we detected the signs of inflammation in H. 
pylori infected gastric mucosa. Based on the above, although the limitations of the model 
should be taken into consideration, one can not exclude that H. pylori infection or 
inflammation elicited by other oral bacteria could possibly contribute to the transition of 
OPMD to carcinoma. Generally, microbial induced chronic inflammation may play a role in 
development and malignant transformation of OPMD. 
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6 Conclusion 
 
Although our work is not suitable to answer the „Chicken or the Egg” problem – that the 
suggested microbial changes are cause or effect of OPMD - in all aspects, but we have found 
that the bacterial colonization of mucosa has already altered in OPMD tissues. Some 
alterations correlate with results of the studies about the putative role of bacteria in OSCC 
development. Our most conspicouos finding was that Fusobacterium nucleatum is 
overrepresented in OPMD tissue samples. Fusobacterium nucleatum was implicated in 
malignant transformation of mucosal cells of gastrointestinal tract, especially in the colon, and 
several studies suggest a similar role for F. nucleatum and other pathogenic bacteria in oral 
mucosal cells [63-68].  
    
1. We found that the microbiome of clinically healthy and OPMD affected oral tissues are 
different: pathogenic bacteria were overrepresented in the mucosal samples of OPMD 
affected tissues. Our results showed that Fusobacterium nucleatum, a bacterium 
implicated in tumorigenesis, is overrepresented in the samples from OPMD affected 
regions. In addition, we observed an increased bacterial diversity in OPMD, compared to 
the microbiota of healthy oral mucosa. These observations may form the basis of novel 
therapeutic approaches preventing oral carcinogenesis in a subset of patients with 
OPMD. 
 
2. The comparison of MALDI-TOF MS and metagenome sequencing provided partially 
overlapping results. 
 
3. We found inflammatory signs both in human OPMD samples and in an in vivo murine 
model of H. pylory-infected gastric mucosa. This may indicate that one can’t exclude 
a potential role for H. pylori infection or inflammation elicited by other oral 
bacteria could play a role in the transition of OPMD to carcinoma in humans. 
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4. Comparison of the microbiome of OPMD samples analysed in our study and the 
microbiome/microbiota of OSCC lesions reviewed in the literature revealed that a wide 
variety of non-overlapping sets of bacterial taxa were found to be associated with OSCC 
lesions. Fusobacterium nucleatum emerged from the data as the best potential 
candidate contributing to te transition of OPMD to OSCC. 
 
 
 
Summary of accomplished objectives 
 
1.  Pathogenic bacteria are overrepresented in the mucosal samples of OPMD affected 
tissues. 
 
2. Specificity and sensitivity of metagenome sequencing and cultivation based MALDI-
TOF MS is markedly different to oral bacteria. 
 
3. Helicobacter pylori caused gastric inflammation in mice could be an experimental 
model of bacterial inflammation triggered carcinogenesis of oral mucosal surfaces. 
(Keeping the limitations caused by differences between subjects and modellorganisms 
in mind.) 
 
4. Fusobacterium nucleatum emerged from the data as the best potential candidate 
contributing to the transition of OPMD to OSCC. 
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Abstract
Oral carcinogenesis often leads to the alteration of the microbiota at the site of the tumor, but data are scarce regarding the
microbial communities of oral potentially malignant disorders (OPMDs). Punch biopsies were taken from healthy and non-
healthymucosa of OPMDpatients to analyze themicrobiome usingmetagenome sequencing. In healthy oral mucosa biopsies the
bacterial phyla Firmicutes, Fusobacteria, Proteobacteria, Actinobacteria and Bacteroidetes were detected by Ion Torrent se-
quencing. The same phyla as well as the phyla Fibrobacteres and Spirochaetes were present in the OPMD biopsies. On the
species level, there were 10 bacterial species unique to the healthy tissue and 35 species unique to the OPMD lesions whereas
eight species were detected in both samples. We observed that the relative abundance of Streptococcus mitis decreased in the
OPMD lesions compared to the uninvolved tissue. In contrast, the relative abundance of Fusobacterium nucleatum, implicated in
carcinogenesis, was elevated in OPMD.We detectedmarkedly increased bacterial diversity in the OPMD lesions compared to the
healthy oral mucosa. The ratio of S. mitis and F. nucleatum are characteristically altered in the OPMD lesions compared to the
healthy mucosa.
Keywords OPMD .Oral microbiome .Metagenome sequencing . Lichen . Leukoplakia
Introduction
Numerous scientific data demonstrate the altered bacterial col-
onization of cancerous tissue, but the causality of microbial
alteration has not clarified yet.
The role of oral microbes in the development of oral poten-
tially malignant disorder (OPMD) and oral squamous cell car-
cinoma (OSCC) is periodically reevaluated, since OPMD or
OSCCmay develop in the absence of the traditional risk factors
like smoking, alcohol consumption and betel nut use [1–3].
While the microbiological background of oral squamous cell
carcinoma was intensively studied in the last two decades, less
attention has been paid to OPMD in this respect [4].
OPMD is a group of disorders of diverse etiologies, fre-
quently associated with tobacco consumption and mutations
in the DNA of oral epithelial cells. A fraction of OPMD un-
dergoes clinical and histomorphological alterations that lead
to the development of OSCC. These disorders include leuko-
plakia, erythroplakia, oral lichen planus, submucous fibrosis,
and actinic cheilitis [5, 6]. In addition, inherited cancer syn-
dromes such as xeroderma pigmentosum and Fanconi’s
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anemia are also associated with an increased incidence of
malignant tumors, among them oral carcinoma [6].
Leukoplakia is defined as ″A white plaque of ques-
tionable risk having excluded (other) known diseases or
disorders that carry no increased risk for cancer″.
Leukoplakia is six times more common among smokers
than among non-smokers [6]. These lesions are divided
into homogenous (simplex) and non-homogenous types.
The non-homogenous types based on the cellular vari-
ability are verrucous leukoplakia, nodular leukoplakia
and erythroleukoplakia [7]. Proliferative verrucous leu-
koplakia (PVL) is a subtype of verrucous leukoplakia
that shows resistance to treatment and a high rate of
malignant transformation. It is more frequent among el-
derly women, in many cases without smoking in the
anamnesis. Distinct histopathological changes, like hy-
perkeratosis with or without dysplasia, may accompany
the transition of PVL to verrucous hyperplasia and
verrucous carcinoma [6].
There are conflicting results regarding the association of leu-
koplakia and human papillomavirus (HPV) infection [6, 8]. The
role of torque teno virus (TTV) [9, 10], Epstein-Barr virus (EBV)
[11] and Candida albicans [8, 12–16] in leukoplakia develop-
ment and carcinogenesis remains to be clarified, too.
Additionally, it has been also demonstrated that specific bacterial
infections like Helicobacter pylori [17] or the intracellular
Mycoplasma salivarium [18] could also be involved in this
process.
A disbalance in the oral microbial flora can be also accom-
panied with leukoplakia and carcinogenesis, as suggested by
the association of periodontal inflammation with leukoplakia
[19] and a changing bacterial flora in the saliva and on the oral
mucosal surfaces of patients with OPMD [20, 21].
Lichen planus (LP) is a chronic, idiopathic, inflammatory
disease of the oral mucosa or the skin, presenting as a white
lesion when it affects the oral cavity (oral lichen planus, OLP).
A crucial aspect of the pathomechanism of OLP is the accu-
mulation of CD8+ T lymphocytes under the basal cell layer of
the oral mucosa, which causes DNA damage and the apopto-
sis of the keratinocytes by antigen-specific cell-mediated im-
mune response, and also basement membrane degradation
[22–25]. According to the most accepted hypothesis, chronic
stimulation from the inflammatory and stromal cells provides
the initial signal which lead to the abolished growth control of
epithelial cells. Additionally, oxidative stress induced DNA
damage could also lead to neoplastic changes, but the initial
event leading to this signal cascade activation has not been
characterized yet. Based on the increasing evidence viral, fun-
gal, and bacterial antigens have all been suggested [26–34] as
a potential initiating factor in LP. If there is a relationship
between the bacterial flora and OLP, the question is whether
the trigger area is in the oral cavity, or at another area of the
body, such as the skin, the gastrointestinal tract, the larynx or
the eyes. If oral bacterial infection could initiate OLP devel-
opment, it is not clear whether a single bacterial species could
initiate the OLP transformations, or is it the interaction of
several species during the process? Additionally, the disturbed
balance of the normal bacterial flora could also be involved in
the initial steps of OLP activation.
In our experimental setup, we examined the oral
microbiome of patients diagnosed with OPMD. We compared
the microbiome of healthy and non-healthy mucosal surfaces.
Using metagenome sequencing, we detected markedly in-
creased bacterial diversity in the OPMD lesions compared to
the healthy oral mucosa. In parallel, in the OPMD lesions there
was a reduced representation of distinct Streptococcus species
that dominate the bacterial community of healthy oral mucosa.
Materials and Methods
Patient Selection
Potential participants were interviewed by the clinical coordi-
nators at the University of Szeged, Faculty of Dentistry. Every
potential participant was informed about the ethical permis-
sion of the study and received both written and oral informa-
tion on the goals and procedures of this study. The initial
participants were selected by volunteering activity and the
detailed questionnaire on family anamnesis, chronic diseases,
medication-, alcohol-, tobacco- and drug consumption, oral
hygiene, and sexual habits was filled out by the volunteers.
Eligibility was determined based on the results of this ques-
tionnaire. Female and male subjects over 18 years of age were
eligible for the study, provided that they were able to provide
signed and dated informed consent and if they did not meet
any of the exclusion criteria. As for the patient group, an
established diagnosis of OPMD was also a requirement. The
exclusion criteria included vital signs outside the acceptable
range at the screening visit (i.e., blood pressure > 140/
90 mmHg, oral temperature > 37 °C, heart rate > 100/
min), pregnancy, the potential subject being a sex work-
er, topical antibiotic treatment up to 7 days before the
screening visit, and the use of the following drugs with-
in 2 months before the screening visit: systemic antibi-
otics, corticosteroids, cytokines, methotrexate or immu-
nosuppressive cytotoxic agents, or large doses of com-
mercial probiotics (≥ 108 CFU mL−1 organisms per
day). No patients were on specific diet, nor on antibi-
otic therapy in the previous 6 months. The clinical char-
acteristics and brief medical history of the patient group
is given in Table 1.
The study protocol conformed to the Declaration of
Helsinki in all respects and was approved by the Institutional
Ethics Committee of the University of Szeged (No. 3161).
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Tissue Sample Collection for Metagenome
Sequencing, Histopathological Assessment
As a classical method for tissue sample collection from muco-
sal lesions in the oral cavity, we used punch biopsy. The biopsy
was made with punches 4 mm in diameter. We collected 2
identical samples from the intralesional area: one sample was
taken for hematoxylin-eosin (HE) staining, and an additional
sample for metagenome sequencing. Additionally, we also col-
lected a third, control specimen from the ipsilateral healthy
mucosa for metagenome sequencing. The specimens contained
the mucosa, and submucosal connective tissue. Samples for
metagenome sequencing were collected in Eppendorf tubes
filled with 20 mM potassium phosphate buffer (pH 7.0), and
stored at −20 °C. Tissue samples for HE staining were fixed in
formaldehyde solution, and sent for histopathological assess-
ment. Pathological dataset (Table 2) included the absence or
presence, together with severity of hyperkeratosis, hyperplasia,
reactive atypia, dysplasia, and lichenoid infiltrate [35].
Metagenomic DNA Isolation
Total DNA was isolated from patient samples as de-
scribed previously, with minor modifications [36].
Briefly, samples (600 μL) were suspended in 650 μL
of extraction buffer (100 mM TrisCl, pH 8.0, 100 mM
EDTA, pH 8.0, 1.5 M NaCl, 100 mM sodium phos-
phate, pH 8.0, 1% CTAB) 3.5 μL proteinase K
(20.2 mg mL−1) and incubated horizontally at 37 °C
for 45 min, next 80 μL of 20% SDS was added and
mixed by inversion for several times with further incu-
bation at 60 °C for 1 h. The sample in each tube was
mixed thoroughly every 15 min. The particles were col-
lected by centrifugation (17,000 g) for 5 min. The su-
pernatant was transferred into clean tubes and was
mixed with equal quantity of phenol chloroform and
isoamyl alcohol (25:24:1) and extracted three times.
DNA was precipitated with 0.7 volume isopropanol,
the pellet was washed with 70% ethanol. Crude DNA
pellets were dried and dissolved in 50 μL of TE buffer
(10 mM Tris-HCl, 1 mM sodium EDTA, pH 8.0).
Metagenomic DNA was quantified using Qubit® 2.0
Fluorometer. Half of total metagenomic DNA from the
Table 2 The histopathological characteristics of the biopsies
patient # 1 2 3 4 5 6 7
OPMD + + + + + + +
hyperkeratosis + ++ +++ +++ + +++ +++
hyperplasia +++ ++ + +++ – +++ +++
reactive atypia – + – + – + +
dysplasia – + – – – – –
lichenoid infiltrate + +++ ++ +++ +++ +++ ++
MT – – – – – – –
Abbreviations: (− no, + mild, ++ moderate, +++ severe; OPMD: oral
potentially malignant disorder; MT: malignant transformation)
Fig. 1 Representative pictures from OPMD tissue samples OPMD
tissue samples with marked hyperkeratosis (a, b – HyKer), acanthosis
and lichenoid infiltrate (a, d – LI). Occasionally there was a marked
verrucous hyperplasia with elongated dermal papillae (c – DP). Note
the regenerative basal cell changes (b – RA/regenerative atypia/), in
contrast to mild dysplasia (d – DY) with focal acantholysis /HE; OM
112×/
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healthy and lesion samples were pooled and stored at
−20 °C for sequencing.
Library Preparation and Sequencing
Ion Torrent PGM Fragment libraries of 200 nt were generated
according to the appropriate protocols (Ion Torrent PGM, Life
Tech, USA). 1 μg pooled metagenomic DNA from each sam-
ple was used for library preparation for each sample. DNA
shearing and end-repair was achieved by Ion Xpress™ Plus
Fragment Library Kit, and DNA Purification was carried out
by PureLink PCR Purification Kit (Thermo Fisher Scientific,
MA). Adapter ligation and nick translation were performed by
Ion Shear Plus Reagents Kit (Thermo Fisher Scientific, MA).
Size selection was performed in 2% agarose gel to enrich the
300–350 nt fragments then library amplification was achieved
by using Platinum® PCR SuperMix (Thermo Fisher Scientific,
MA). ION Library TaqMan qPCR was used for quantitation
and Ion Xpress Template 200 ePCR kit was used for the emul-
sion PCR. Sequencing was performed on Ion Torrent Personal
Genome Machine™ using Ion 318 chip. Ion Torrent Personal
Genome Machine™ sequencing resulted 872,798 sequence
reads for sample 1 (control) with an average read length of
219 ± 71 bases and 644,200 sequence reads for sample 2
(diseased) with an average read length of 220 ± 72 bases.
Quality Assurance
The MG-RAST software performs a QC (quality control) and
an automatic normalization of the FASTQ sequence. For the
taxonomical analyses, maximum e-value cut-off of 10−15,
minimum percent identity cut-off 90% and minimum align-
ment length cut-off 40 nt settings were applied. The overall
community composition was determined using the M5nr da-
tabase. Hits for the eukaryotic data were removed and relative
abundance of the bacterial data was calculated.
Swab Sample Collection
We used cotton swabs for collecting bacterial samples. Two
individual samples were taken from each patient, one from
the surface of the lesion, and another one from the ipsilateral
healthy (non-involved) mucosa. The swabs were rolled 4 times
over the chosen areas. Then the swabs were placed in anaerobic
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Fig. 2 Distribution of
taxonomic domains Significant
differences were not found in the
distributions of taxonomic
domains between the healthy
tissue and the OPMD lesion.
6.78% of bacterial domains were
detected in healthy area compared
6.87% of bacterial domains in
white lesions of oral mucosa
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Fig. 3 Bacterial diversity a
Metagenome sequencing revealed
that the bacterial diversity in the
OPMD biopsies was higher
compared to the healthy oral
mucosa. Within the Bacteria
domain Firmicutes,
Fusobacteria, Proteobacteria,
Actinobacteria, Bacteroidetes
phyla were present in the healthy
oral mucosa. In the OPMD
biopsies the same phyla were
identified in descending order of
relative abundance; however, two
additional phyla, Fibrobacteres
and Spirochaetes were observed,
too. b Metagenome sequencing
detected 18 different bacterial
species in healthy tissue and 43
species in the OPMD lesion.
Eight bacterial species were
detected in both samples
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transport medium (AnaerobeSystems, CA) and sent immedi-
ately to the Institute of Clinical Microbiology, University of
Szeged, for Fusobacterium nucleatum cultivation.
Fusobacterium nucleatum qPCR
DNA templates for qPCR were prepared from the undiluted
BHI suspensions of the oral swabs by the QiAmp Stool Mini
DNA Kit (Qiagen, Germany) as recommended by the supplier.
Subsequent quantitative RT-PCRs for Fusobacterium
nucleatum were done in StepOne RT-PCR instrument
(Invitrogen, CA) using 5 μL Brilliant II master mix (Agilent),
primers FnucF CTTAGGAATGAGACAGAGATG and FnucR
TGATGGTAACATACGAAAGG 0.2 μL (35 pmole/μL) each,
1 μL of template sample and the following cycling conditions:
starting denaturation and hot start activation 95 °C 10 min,
95 °C 15 s, 56 °C 15 s and 72 °C 30 s, 40×; and a melting curve
from 72 °C to 95 °C [37] CFUs were calculated comparing the
means of threshold cycles to ones of a F. nucleatum 10-fold
serial dilution samples prepared with the same kit.
Data Analysis
For the comparison of the numerical data, the Mann-Whitney
U test was used in SPSS 21.0 (IBM, NY).
Results
Sample selectionwas based on the histological analysis of oral
potentially malignant disorder. Figure 1 shows representative
pictures of the OPMD tissue samples with marked hyperker-
atosis, acanthosis and lichenoid infiltration. Table 1. describes
the brief medical history of selected patients (Selection criteria
has been found in Materials and methods). Detailed histolog-
ical classification summarized in Table 2.
OPMDHealthy
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Fig. 4 Comparison of the detected bacterial speciesMetagenome sequencing detected 18 different bacterial species in healthy tissue and 43 species in
the OPMD lesion
G. Decsi et al.
First, we determined the ratio of bacterial DNA in our
sample. As punch biopsy samples contain a high amount of
human tissue, this step helped us to define the limitation of the
study. In healthy oral mucosa samples, 6.78% of the sequence
reads were annotated to the domain Bacteria. The ratio of
bacterial sequences was similar (6.87%) in the pooled
OPMD DNA samples (Fig. 2).
Metagenome sequencing revealed that the bacterial
diversity in the OPMD biopsies was higher compared
to the healthy oral mucosa. Within the Bacteria domain
F i rm i c u t e s , F u s o b a c t e r i a , P ro t e o b a c t e r i a ,
Actinobacteria, Bacteroidetes phyla were present in the
healthy oral mucosa. In the OPMD biopsies the same
phyla, i.e. Firmicutes, Fusobacteria, Proteobacteria,
Actinobacteria and Bacteroidetes were identified in de-
scending order of relative abundance; however, two ad-
ditional phyla, Fibrobacteres and Spirochaetes were ob-
served, too (Fig. 3a).
Table 3 Comparison of bacterial diversity in the healthy mucosa and the OPMD lesion
Species Phylum Healthy OPMD
Streptococcus mitis Firmicutes 32,73% 18,62%
Streptococcus pneumoniae Firmicutes 25,45% 13,79%
Gemella haemolysans Firmicutes 7,27% 1,38%
Rothia dentocariosa Actinobacteria 3,64% 0,021
Fusobacterium nucleatum Fusobacteria 3,64% 5,52%
Actinomyces urogenitalis Actinobacteria 1,82% 0,69%
Streptococcus oralis Firmicutes 1,82% 4,14%
Haemophilus influenzae Proteobacteria 1,82% 1,38%
Fusobacterium sp. 3_1_36A2 Fusobacteria 3,64% 0
Fusobacterium sp. 4_1_13 Fusobacteria 3,64% 0
Porphyromonas gingivalis Bacteroidetes 1,82% 0
Prevotella bergensis Bacteroidetes 1,82% 0
Gemella morbillorum Firmicutes 1,82% 0
Streptococcus infantis Firmicutes 1,82% 0
Neisseria meningitidis Proteobacteria 1,82% 0
Neisseria subflava Proteobacteria 1,82% 0
Enhydrobacter aerosaccus Proteobacteria 1,82% 0
Psychrobacter sp. PRwf-1 Proteobacteria 1,82% 0
Streptococcus parasanguinis Firmicutes 0 4,83%
Fibrobacter succinogenes Fibrobacteres 0 4,14%
Streptococcus sp. M143 Firmicutes 0 4,14%
Campylobacter concisus Proteobacteria 0 4,14%
Streptococcus sanguinis Firmicutes 0 2,76%
Streptococcus sp. M334 Firmicutes 0 2,76%
Prevotella melaninogenica Bacteroidetes 0 2,07%
Capnocytophaga ochracea Bacteroidetes 0 2,07%
Streptococcus vestibularis Firmicutes 0 2,07%
Veillonella parvula Firmicutes 0 2,07%
Rothia mucilaginosa Actinobacteria 0 2,07%
Corynebacterium efficiens Actinobacteria 0 1,38%
Corynebacterium matruchotii Actinobacteria 0 1,38%
Granulicatella adiacens Firmicutes 0 1,38%
Streptococcus gordonii Firmicutes 0 1,38%
Streptococcus salivarius Firmicutes 0 1,38%
Leptotrichia buccalis Fusobacteria 0 1,38%
Actinomyces sp. oral taxon 171 Actinobacteria 0 0,69%
Thermomonospora curvata Actinobacteria 0 0,69%
Capnocytophaga gingivalis Bacteroidetes 0 0,69%
Gemella morbillorum Firmicutes 0 0,69%
Streptococcus pyogenes Firmicutes 0 0,69%
Streptococcus sp. C300 Firmicutes 0 0,69%
Streptococcus sp. oral taxon 071 Firmicutes 0 0,69%
Streptococcus thermophilus Firmicutes 0 0,69%
Parvimonas micra Firmicutes 0 0,69%
Eubacterium saburreum Firmicutes 0 0,69%
Veillonella sp. 3_1_44 Firmicutes 0 0,69%
Veillonella sp. oral taxon 158 Firmicutes 0 0,69%
Fusobacterium sp. 1_1_41FAA Fusobacteria 0 0,69%
Fusobacterium sp. 3_1_27 Fusobacteria 0 0,69%
Fusobacterium sp. 7_1 Fusobacteria 0 0,69%
Lautropia mirabilis Proteobacteria 0 0,69%
Delftia acidovorans Proteobacteria 0 0,69%
Simonsiella muelleri Bacteroidetes 0 0,69%
Treponema vincentii Spirochaetes 0 0,69%
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On the species level, 18 bacterial species were detect-
ed in the healthy tissue, 35 species were unique for the
OPMD lesions and eight bacterial species were detected
both in healthy oral mucosa and the OPMD biopsy
samples (Fig. 3b). Metagenome sequencing showed
markedly increased bacterial diversity in the OPMD tis-
sue samples. Analysis of bacterial species detected 2.38
fold increasing in diversity of the OPMD lesions
(Fig. 4, Table 3).
Based on the data of metagenome sequencing, the
relative abundance of Streptococcus sp. did not show
significant difference between the healthy tissue and
the OPMD lesions: it was 61.82% in healthy tissue
and 58.62% in OPMD, respectively (Fig. 5a) However,
the relative abundance of the Streptococcus mitis was
found to be dramatically decreased in OPMD: it was
only 18.62%, compared to 32.73% in the healthy tissue
(Fig. 5b). Moreover, examining all Streptococcus species
their prevalence in the OPMD lesions was determined to
be more diverse compared to the healthy tissue (Table
3).
According to the results of metagenome sequencing, the
ratio of Fusobacterium nucleatum was higher in the OPMD
lesions (5.52%), compared to the healthy tissue (3.64%)
(Fig. 6). Relative abundance of Fusobacterium nucleatum
(5.52%) and Streptococcus oralis (4.14%) bacteria were
identified in a larger portion among the overlapping bacte-
ria in OPMD while 3.64 and 1.82% were observed in
healthy tissue, respectively). The abundances of the species
Gemella haemolysans (1.38%), and the above mentioned S.
mitis (18.62%) decreased markedly in OPMD as compared
to the healthy tissue (7.27% and 32.73%) (Table 3).
35 different bacterial species has been found in the
OPMD lesions which has not been presented in the
healthy tissue, e.g., Streptococcus parasanguinis,
Fibrobacter succinogenes, Campylobacter concisus,
Streptococcus sanguinis , Rothia muci laginosa,
Prevotella melaninogenica, Capnocytophaga ochracea,
Streptococcus vest ibularis , Veil lonella parvula,
Corynebac t e r i um e f f i c i e n s , Corynebac t e r i um
matruchotii, Granulicatella adiacens, Streptococcus
gordonii, Streptococcus salivarius, Leptotrichia buccalis,
Thermomonospora curvata, Capnocytophaga gingivalis,
Streptococcus pyogenes Streptococcus thermophiles,
Parvimonas micra, Eubacterium saburreum, Lautropia
mirabilis, Delftia acidovorans, Simonsiella muelleri,
Treponema vincentii, etc., in descending order of the
abundances.
As F. nucleatum was implicated in carcinogenesis in
several cancers [38], we verified the results of
metagenome sequencing by F. nucleatum-specific
qPCR. As Fig. 7 shows, the number of bacteria
(CFUs) is significantly higher (P < 0.0001) in samples
taken from OPMD lesions than in those from the
healthy mucosa. This difference is remarkable, even
when one considers the high inter-individual variability
of the samples.
Discussion
It was suggested that OPMD was frequently associated
with alcohol and tobacco consumption, and affected
mainly males in their fifties, but the practice shows that
18.62%
81.38%
Streptococcus mitis
Other bacteria
32.73%
67.27%
Streptococcus mitis
Other bacteria
b
Healthy OPMD
58.62%
41.38%
Streptococcus sp.
Other bacteria61.82%
38.18% Streptococcus sp.
Other bacteria
a
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Fig. 5 Ratio of Streptococci in
the mucosal lesion a The ratio of
Streptococci to all oral bacteria
was not significantly different in
the healthy tissue compared to the
OPMD lesion. b The ratio of
Streptococcus mitis dramatically
decreased in the OPMD, as
compared to the healthy tissue
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a much wider variety of patients are affected [1, 3].
Accordingly, we included a wide range of patients in
our sample, without strict limitations on age or sex.
In our study we compared the microbiome and microbiota
of healthy and the OPMD tissues of oral cavity.
The association of Fusobacterium nucleatum with
oral carcinoma was documented [38, 39]. Moreover, it
was suggested that distinct subspecies of F. nucleatum,
such as F. nucleatum subsp. polymorphum and F.
n u c l e a t u m s u b s p . v i n c e n t i i , m a y p l a y a n
etiopathogenetic role in oral carcinogenesis [40]. A
study also described the presence of F. nucleatum in
desquamative gingivitis [41]. However, our report shows
the first time the presence of Fusobacterium nucleatum
in lesion biopsies of OPMD patients.
The finding that F. nucleatum is present in OPMD
may be exploited to develop a novel therapeutic strategy
of distinct oral disorders such as oral lichen planus. In
addition, one may speculate that a targeted antibiotic
therapy could be beneficial in preventing the develop-
ment of oral cancer in a subset of OPMD patients.
We observed that the relat ive abundance of
Streptococcus mitis decreased dramatically in the patho-
logical niche. Since Streptococci are characteristic com-
ponents of the oral flora, the quantitative analysis of
these bacteria is indispensable for the understanding of
pathological processes. Streptococci comprise of a wide
variety of bacterial species that interact with other mem-
bers of the oral microbiome. It was suggested that S.
mitis is involved in the maintenance of a healthy oral
flora by affecting adhesion and biofilm formation by
periodontal pathogens to [42–44].
Therefore, it is an interesting and important finding
that the relative abundance of S. mitis in the OPMD
lesions decreased to nearly the half of the healthy area.
This observation may possibly be exploited for thera-
peutic purposes: similarly to the reconditioning of vag-
inal Lactobacillus balance [45], the restitution of S.
mitis niche in OPMD could also have beneficial effects
[46].
Taken together, we presented evidence for the alter-
ation of microbiome and microbiota of OPMD patients.
We detected an increased bacterial diversity in the
OPMD lesions compared to the healthy oral mucosa.
In addition, decreased relative abundance of S. mitis
and an increased relative abundance of F. nucleatum
may play a role in the transition of OPMDs to oral
cancer.
Although our study is not suitable to answer the
BChicken or the Egg^ problem in all aspects, but we
have found that the bacterial colonization of mucosa
has already altered in OPMD tissues. These observa-
tions may form the basis of novel therapeutic ap-
proaches preventing oral carcinogenesis in a subset of
patients with OPMD.
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Abstract
Background: Helicobacter pylori	 can	 cause	 many	 gastrointestinal	 and	 also	 extra-	
gastrointestinal	disorders	and	is	a	major	risk	factor	for	gastric	carcinoma	and	MALT	
lymphoma.	 Currently,	 numerous	 antibiotic-	based	 therapies	 are	 available;	 however,	
these	 therapies	 have	numerous	drawbacks,	mainly	 due	 to	 increasing	prevalence	of	
antibiotic	resistant	strains.	Thus,	there	is	an	urgent	need	to	develop	novel	therapeutic	
agents	against	H. pylori	infections.
Materials and Methods: In	 this	 study,	 the	 anti-	H. pylori	 activity	 of	 2:1	 mixture	 of	
Satureja hortensis	and	Origanum vulgare	subsp.	hirtum	essential	oils	(2MIX)	was	investi-
gated	in	vivo.	After	screening	in	vitro	cytotoxicity	of	2MIX	on	mammalian	cell	lines,	the	
therapeutic	efficiency	was	studied	in	a	mouse	model,	where	changes	in	H. pylori colo-
nization	were	detected	by	PCR	and	histology	of	gastric	samples.	The	immune	reaction	
of	mice	was	 tested	 based	 on	 cytokine	 and	 chemokine	 production,	 and	 the	 in	 vivo	
toxicity	of	2MIX	was	also	investigated	by	measuring	ALT	and	AST	enzyme	activities	
and	Cyp3a11	and	HO-	1	mRNA	levels	in	livers	of	mice.
Results: 2MIX	had	not	shown	in	vitro	cytotoxicity	against	cell	lines,	only	the	highest	con-
centration	caused	significant	decrease	in	their	survival	rates.	In	the	in	vivo	experiments,	
2MIX	successfully	eradicated	 the	pathogen	 in	70%	of	 the	mice.	We	could	not	detect	
toxicity	or	altered	cytokine	and	chemokine	balance	after	in	vivo	treatments	in	mice.
Conclusions: These	results	show	that	2MIX	is	effective	in	reducing	H. pylori coloniza-
tion	suggesting	that	this	essential	oil	mixture	has	great	potential	as	a	new,	effective,	
and	safe	therapeutic	agent	against	H. pylori.
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subsp. hirtum essential oils: in vivo therapeutic efficiency 
against Helicobacter pylori infection
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1  | INTRODUCTION
Helicobacter pylori	is	a	gram-	negative,	spiral-	shaped,	microaerophilic	
bacterium	with	an	ability	to	colonize	the	acidic	environment	of	the	
stomach.	This	pathogen	infects	more	than	half	of	the	world’s	human	
population,	 and	 it	 is	 considered	 to	 be	 the	major	 cause	 of	 chronic	
gastritis,	peptic	ulcer	disease,	gastric	cancer,	and	mucosa-	associated	
lymphoid	 tissue	 (MALT)	 lymphoma.1–4	 Furthermore,	 H. pylori 
	infection	is	reported	to	be	associated	not	only	with	gastrointestinal	
diseases,	 but	 also	with	many	 extra-	gastrointestinal	 disorders,	 such	
as	 hematological,	 cardiovascular,	 neurological,	 metabolic,	 and	 skin	
diseases.5–7
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The	survival	capabilities	of	H. pylori	within	the	stomach	make	 it	
difficult	to	eradicate,	and	effective	treatment	requires	multidrug	reg-
imens.	Most	of	 them	 include	two	antibiotics	 (usually	selected	from	
clarithromycin,	 metronidazole,	 amoxicillin,	 and	 tetracycline)	 com-
bined	with	a	proton-	pump	inhibitor	and/or	a	bismuth	compound.8–12 
These	current	 therapies	are	generally	effective,	but	can	 fail	due	 to	
the	 increasing	prevalence	of	antibiotic	resistance	or	 lack	of	patient	
compliance;	 in	addition,	 they	can	cause	adverse	 side	effects.	Thus,	
there	is	an	urgent	need	to	develop	novel	therapeutic	agents	against	
H. pylori.
Aromatic	 plants	 are	 regarded	 as	 a	 promising	 source	 of	 new	
and	 highly	 potent	 antibacterial	 agents.	 In	 the	 last	 15	years,	 sev-
eral		research	groups	have	investigated	essential	oils	from	different	
plants	for	their	in	vitro	anti-	H. pylori	activity	and	presented	encour-
aging	results.13,14	Still,	only	a	few	studies	reported	their	in	vivo	effi-
ciency,15,16	while	none	of	them	tested	essential	oil	mixtures,	what	
authors	 of	 this	 study	 consider	 very	 promising	 due	 to	 low	 ability	
of H. pylori	 to	 develop	 resistance	 to	 a	 great	 number	 of	 terpenoid	
structures.
In	our	previous	 study,	nine	aromatic	plant	 species,	belonging	 to	
three	 families	 (Lamiaceae, Apiaceae,	 and	 Asteraceae)	 were	 selected	
for	 testing	 in	vitro	anti-	H. pylori	activity.	Firstly,	 the	essential	oils	of	
these	plants	were	examined	one	by	one,	 and	 then,	 the	most	effec-
tive		essential	oils	were	tested	in	a	combinatory	experimental	set-	up.	
Finally,	 the	 2:1	 mixture	 of	 Satureja hortensis	 (summer	 savory)	 and	
Origanum vulgare	subsp.	hirtum	 (Greek	oregano)	showed	the	highest	
inhibitory	effect	against	H. pylori	growth,	probably	due	to	the	syner-
gistic	effects	of	the	terpenoid	compounds.17	Based	on	these	results,	
in	this	study,	this	2:1	mixture	(2MIX)	was	used	for	in	vitro	cytotoxic-
ity	and	 in	vivo	therapeutic	examinations	to	confirm	 its	anti-	H. pylori 
	activity	in	vivo.	This	research	was	carried	out	with	ultimate	aim	which	
is	to	support	further	investigations	toward	clinical	studies	and	intro-
duction	of	essential	oil	therapy	as	additional	therapy	to	antibiotics	for	
H. pylori	patients.
2  | METHODS
2.1 | Plant material and essential oil preparation
Essential	oils	were	prepared	as	described	previously.17	Briefly,	the	
plant	material	of	S. hortensis	and	O. vulgare	subsp.	hirtum	was	pur-
chased	 from	 the	 organic	 farm	 “Farago,”	Orom,	 Vojvodina,	 Serbia.	
The	 voucher	 specimens	 were	 prepared	 and	 identified	 by	 Goran	
Anačkov,	PhD,	and	deposited	at	the	Herbarium	of	the	Department	
of	Biology	and	Ecology,	University	of	Novi	Sad	Faculty	of	Sciences,	
Serbia	 (2-	1542	 and	 2-	1539	 for	 S. hortensis	 and	 O. vulgare	 subsp.	
hirtum,	 respectively).	 The	 plant	 material	 was	 collected	 in	 a	 flow-
ering	 stage	 and	 subsequently	 air-	dried	 and	 finely	 grounded.	 The	
essential	 oils	 were	 isolated	 by	 hydrodistillation	 according	 to	 the	
recommended	 procedure	 by	Ph.	 EUR.	 IV.18	 The	 2:1	mixture	 (v/v)	
of S. hortensis	and	O. vulgare	subsp.	hirtum	essential	oil	(2MIX)	was	
prepared.	The	obtained	2MIX	was	stored	at	−20°C	prior	to	further	
experiments.
2.2 | In vitro cell viability assay
Four	different	cell	lines	were	chosen	to	study	the	cytotoxicity	of	2MIX:	
HepG2	 human	 hepatocarcinoma,	 THP-	1	 human	 monocyte,	 RAW	
264.7	mouse	macrophage,	and	B16F1	mouse	melanoma	cell	lines.	All	
of	them	were	maintained	in	a	37°C	humidified	incubator	with	5%	CO2,	
in	the	appropriate	cell-	specific	medium	which	consisted	of	EMEM	sup-
plemented	with	10%	FBS,	1%	NEAA,	1%	l-	glu	for	HepG2,	RPMI-	1640	
with	 10%	 FBS,	 0.05	mmol/L	 2-	mercaptoethanol	 for	 THP-	1,	 DMEM	
with	10%	FBS,	1%	NEAA,	1%	VIT,	1%	l-	glu,	0.01%	Na-	pyruvate	for	
B16F1,	and	DMEM	F-	12	with	10%	FBS	for	RAW	264.7.
Cells	were	 cultured	 in	 2MIX-	containing	 or	 control	medium	 (me-
dium	without	2MIX)	for	48	hours.	Based	on	previous	in	vitro	inhibitory	
effect	of	the	2MIX	on	H. pylori	growth,17	dosages	of	treatments	were	
0.01%,	0.001%,	and	0.0001%.	Oils	were	incorporated	to	the	media	by	
sonication.	Morphological	changes	in	the	cells	were	observed	micro-
scopically,	and	the	survival	rates	were	evaluated	by	trypan	blue	exclu-
sion	24	and	48	hours	after	treatments.
2.3 | Bacterial strain and culture conditions
Metronidazole	 resistant,	 mouse-	adapted	 H. pylori	 SS1	 strain19	 used	
here	was	kindly	provided	by	Dr.	Eliette	Touati	 (Unité	de	Pathogenése	
de	Helicobacter	Département	de	Microbiologie,	Pasteur	Institute,	Paris,	
France)	and	grown	on	brain	heart	infusion	broth	medium	(BHIB;	HiMedia,	
Mumbai,	India)	supplemented	with	2.5%	yeast	extract	(Torlak,	Belgrade,	
Serbia),	 5%	 horse	 serum	 (Gibco,	 Gaithersburg,	 MD,	 USA),	 and	 2%	
IsoVitaleX	(BD,	Le	Pont	de	Claix,	France).	The	bacterium	cultures	were	
maintained	under	microaerobic	conditions	(5%	O2,	10%	CO2,	85%	N2)	
and	moist	atmosphere.	The	purity	of	the	culture	was	checked	regularly.
2.4 | Animal model
Specific-	pathogen-	free	 six-	 to	 eight-	week-	old	 female	 Balb/c	 mice	
were	obtained	from	Charles	River	(Germany).	They	were	maintained	
ab	three	to	five	animals	per	cage,	with	wood	pellet	bedding,	on	com-
mercial	diet	and	water	ad	libitum.
Infections	with	H. pylori	 SS1	 strain	were	established	 three	times	
over	a	five-	day	period	by	administration	via	feeding	needle	of	100	μL	
bacterium	suspension	 in	BHIB	 (109	CFU/mL).	Negative	control	mice	
remained	uninfected.	One	week	later,	some	animals	were	sacrificed	to	
verify	the	success	of	infection	by	PCR	before	treatments.	At	the	same	
time,	 infected	mice	were	 randomly	 divided	 into	 three	 groups.	 First	
of	 them	 remained	 untreated	 (positive	 control),	 second	was	 treated	
by	2MIX	(43.75	μL/kg	body	weight)	and	third	with	sunflower	oil,	the	
	diluent	of	2MIX	 (Table	1).	Treatments	were	carried	out	 in	50	μL	vol-
ume,	 three	times	over	a	five-	day	period	by	 feeding	needle.	Another	
week	later,	blood	samples	were	collected	via	cardiac	puncture	and	all	
of	the	animals	were	sacrificed	under	anesthesia.	The	entire	stomach	of	
each	mouse	was	removed	for	assessment	of	H. pylori	colonization,	and	
liver	samples	were	collected	for	toxicological	investigations.
All	animal	experiments	were	performed	in	accordance	with	national	
(1998.	 XXVIII;	 40/2013)	 and	 European	 (2010/63/EU)	 animal	 ethics	
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guidelines.	The	experimental	protocols	were	approved	by	the	Animal	
Experimentation	 and	 Ethics	 Committee	 of	 the	 Biological	 Research	
Centre	 of	 the	 Hungarian	 Academy	 of	 Sciences	 and	 the	 Hungarian	
National	Animal	Experimentation	and	Ethics	Board	(clearance	number:	
XVI./03521/2011.)
2.5 | Assessment of H. pylori colonization levels
2.5.1 | PCR
After	 the	 gastric	 samples	were	 homogenized	 in	 100	μL	 lysis	 buffer	
(ZR	Kit),	DNA	was	isolated	using	ZR	Fecal	DNA	MiniPrep™	kit	(Zymo	
Research	Corporation,	Irvine,	CA,	USA)	according	to	the	manufactur-
er’s	protocol.
A	 229-	bp	 region	 of	 the	 16S	 rRNA	 sequence	 is	 100%	 homolo-
gous	in	most	H. pylori	strains.20	 In	the	PCR	analysis,	specific	primers	
for	a	part	of	this	region,	5′-	TCG	GAA	TCA	CTG	GGC	GTA	A-	3′20	and	
	5′-	GCG	TCA	GTA	ATG	TTC	CAG	CA-	3′	(designed	for	this	study),	were	
used.	PCR	was	performed	at	95°C	for	1	minute,	followed	by	35	cycles	
at	95°C	 for	30	seconds,	60°C	 for	30	seconds,	72°C	 for	30	seconds,	
and	a	final	step	at	72°C	for	4	minutes.	The	202-	bp	PCR	products	were	
separated	on	2%	 (w/v)	 agarose	gels,	 stained	with	ethidium	bromide	
and	visualized	using	a	UV	transilluminator.
2.5.2 | Histology
Gastric	samples	were	fixed	in	4%	buffered	formaldehyde	for	24	hours,	
embedded	in	paraffin	blockers	and	cut	into	4	μm	serial	sections	(Leica	
RM2245).	 Each	 sample	 was	 autostained	 (Leica	 ST5020)	 by	 routine	
Giemsa	for	highlighting	H. pylori	bacteria.	Slides	were	archived	by	vir-
tual	microscopy	using	slide	scanner	(3DHistech,	Budapest,	Hungary).
2.6 | Preparation of serum samples and 
cytokines analysis
Collected	blood	samples	were	allowed	to	clot	for	30	minutes	at	room	
temperature	 and	 then	 overnight	 at	 4°C.	 Serum	 samples	 were	 col-
lected	by	centrifugation	at	850	x	g	for	5	minutes	and	stored	at	−80°C	
until	analysis.
Serum	 cytokines	 were	 analyzed	 by	 Proteome	 Profiler	 Mouse	
Cytokine	Array	Panel	(R&D	Systems,	Minneapolis,	MN,	USA)	according	
to	the	manufacturer’s	instructions.	A	known	volume	of	250	μL	of	pooled	
serum	samples	was	applied	for	each	membrane,	and	the	chemilumines-
cent	signal	was	detected	using	Odyssey	imaging	system	(LI-	COR).
2.7 | Analysis of in vivo toxicity
2.7.1 | Liver AST and ALT enzyme activities
The	 liver	 aspartate	 aminotransferase	 (AST)	 and	 alanine	 aminotrans-
ferase	(ALT)	enzyme	activities	were	determined	using	the	ALT	(GPT)	
and	 AST	 (GOT)	 stable	 liquid	 reagent	 kits	 (Clinichem,	 Budapest,	
Hungary),	according	to	the	manufacturer’s	instructions.
In	 brief,	 the	AST	 assay	 is	 based	 on	 two	 reactions.	The	 first	 one	
is	 catalyzed	 by	 AST	 and	 includes	 two	 substrates:	 l-aspartate	 and	
	α-	ketoglutarate.	Second	reaction	consists	of	transformation	of	oxalac-
etate,	released	in	the	first	reaction,	by	malate	dehydrogenase	with	the	
help	of	NADH	coenzyme,	both	contained	in	the	reagent.	The	oxidore-
ductive	process	of	NADH/NAD+	is	indicated	by	a	decrease	in	absor-
bance	at	340	nm	which	correlates	with	liver	AST	activity.
Similarly,	 in	 ALT	 assay,	 ALT	 firstly	 catalyzes	 the	 transformation	
of  l-	alanin	 and	 α-	ketoglutarate.	 The	 pyruvate	 released	 in	 before	
mentioned	 reaction	 is	 transformed	by	 lactate	dehydrogenase	 in	 the	
presence	 of	 NADH,	 both	 contained	 in	 the	 reagent.	 NADH/NAD+ 
oxidoreductive	 process	 shows	 a	 decrease	 in	 absorbance	 at	 340	nm	
which	correlates	with	liver	ALT	activity.
Before	 carrying	 out	 assays,	 liver	 tissue	 homogenates	were	 pre-
pared	in	TRIS	buffer	(pH	7.5)	and	supernatants	were	used	for	further	
ALT	and	AST	activities	estimations.	Afterward,	the	total	protein	con-
tent	in	each	homogenate	was	determined.	The	enzyme	activities	were	
expressed	according	to	NADH	calibration	curve	measured	on	340	nm	
using	NADH	solutions	in	TRIS	buffer	(pH	7.5).	Samples	were	prepared	
according	 to	 manufacturer’s	 instructions	 and	 after	 an	 one-	minute	
	incubation	at	37°C,	changes	in	absorbance	at	340	nm	were	measured	
each	 30	seconds	 (ΔA/min)	 during	 two	 minutes.	 Consequently,	 all	
	results	were	expressed	as	NADH	mmol/min	mg	proteins.
2.7.2 | RT- PCR analysis of heme oxygenase 1 and 
cytochrome P450 mRNA
Liver	RNA	was	extracted	with	TRIzol®	(Life	Technologies,	Waltham,	MA,	
USA)		according	to	the	manufacturer’s	instructions.	Total	RNA	(1	μg)	was	
	reverse	transcribed	using	the	High	Capacity	cDNA	Reverse	Transcription	
Kit	 (Life	 Technologies),	 according	 to	 the	 manufacturer’s	 instructions.	
Real-	time	 PCR	 reactions	 were	 performed	 using	 Agilent	 Technologies	
Mx3005P	 cycler	 using	 glyceraldehyde-	3-	phosphate	 dehydrogenase	
(GAPDH)	as	internal	standard.	Each	reaction	was	performed	in	duplicate	
and	contained	10	pmol	of	specific	primers	 (heme	oxygenase	1	 (HO-	1)	
fwd	 	5′-	GAA	CCC	AGT	CTA	TGC	CCC	AC-	3′,	 rev	 5′-	GGC	GTG	CAA	
GGG	ATG	ATT	TC-	3′;	cytochrome	P450,	family	3,	subfamily	a,	polypep-
tide	11	(Cyp3a11)	fwd	5′-	AGG	AGG	ATC	ACA	CAC	ACA	GTT	G-	3′,	rev	
	5′-	CCC	AGG	TTT	CCA	GTG	AGA	GAG-	3′;	GAPDH	 fwd	5′-	ACT	CTT	
CCA	CCT	TCG	ATG	CC-	3′,	rev	5′-	GGC	CTC	TCT	TGC	TCA	GTG	TC-	
3′),	2×	Brilliant	II	SYBR	Green	qPCR	Master	Mix	(Agilent	Technologies,	
Santa	Clara,	CA,	USA),	0.375	μL	of	provided	reference	dye	(diluted	1:500	
in	nuclease-	free	H2O)	and	4	μL	of	cDNA	in	a	25-	μL	reaction.	Samples	
without	cDNA	were	included	as	negative	controls.	Cycle	threshold	(Ct)	
values	were		obtained	for	each	gene	of	interest	and	the	GAPDH	internal	
TABLE  1 Treatment	schedules	for	groups	of	mice
Group name n
Helicobacter pylori 
infection Treatment
Negative	control 5 − –
2MIX-	treated 12 + 2MIX
Sunflower	oil-	treated 5 + Sunflower	oil
Positive	control 5 + –
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standard.	Gene	expression	was	normalized	to	GAPDH	and	represented	
as	ΔCt	values.	For	each	sample,	the	mean	of	the	ΔCt	values	was	calcu-
lated.	Relative	gene	expression	was	normalized	to	1.0	(100%)	of	controls.
3  | RESULTS
3.1 | Cytotoxicity against mammalian cell lines
As	 in	 the	preliminary	 in	vitro	studies,	2MIX	showed	high	antibacte-
rial	activity	against	H. pylori,17	we	aimed	to	test	cytotoxicity	of	2MIX	
against	 four	 different	 mammalian	 cell	 lines	 (RAW	 264.7,	 B16F1,	
HepG2,	and	THP-	1)	before	the	in	vivo	experiments.	Cells	were	treated	
with	 cell	 line-	specific	medium	alone	or	medium	containing	2MIX	at	
three	different	concentrations	(0.01%,	0.001%,	or	0.0001%).	After	24	
and	48	hours,	the	viability	of	the	cells	was	determined	by	trypan	blue	
exclusion	assay.	2MIX	had	not	caused	significant	decrease	in	survival	
rates	of	the	cells,	except	at	the	highest	concentration	(Fig.	1).
3.2 | In vivo antibacterial effect
After	 verifying	 low	 levels	 of	 cytotoxicity,	 we	 tested	 the	 effect	 of	
2MIX	on	H. pylori	colonization	in	mice.	On	the	first	week	of	the	in	vivo	
	experiments,	 mice	 were	 infected	 with	 the	 mouse-	adopted	H. pylori 
SS1	 strain.	On	 the	 third	week,	 establishment	 of	 infection	was	 con-
firmed	by	PCR	and	histology	and	the	infected	mice	were	treated	by	
2MIX	or	sunflower	oil	(diluent	of	the	therapeutic	agent).	An	additional	
group	of	infected	mice	remained	untreated	as	a	positive	control,	and	
we	had	an	uninfected,	untreated	negative	control	group	(Table	1).	On	
the	fifth	week,	mice	were	sacrificed	and	the	colonization	of	H. pylori 
was	tested	by	PCR	and	histology	in	gastric	samples.
We	could	verify	the	long-	term	H. pylori	infection	of	mice	(Fig.	2).	
In	the	2MIX-	treated	group,	only	30%	of	the	animals	remained	pos-
itive	for	the	presence	of	the	pathogen,	confirmed	by	the	PCR	anal-
ysis	 (Fig.	3).	As	expected,	 sunflower	oil	had	no	effect	on	H. pylori 
infection.	 In	 the	 negative	 control	 group,	 absence	 of	 the	 bacteria	
was	 also	 confirmed.	 These	 in	 vivo	 results	 suggest	 promising	 an-
ti-	H. pylori		therapeutic		potential	of	2MIX.
F IGURE  1 Effect	of	2MIX	on	viability	of	the	mammalian	cell	lines.	(A)	Twenty-	four	hours	after	treatments:	Only	the	highest	concentration	of	
2MIX	caused	significant	decrease	in	survival	rates	of	B16F1	(P=.0001)	and	THP-	1	(P<.0001)	cells,	but	not	RAW	264.7	and	HepG2.	(B)	Forty-	
eight	hours	after	treatments:	Also	only	the	highest	concentration	of	2MIX	caused	significant	decrease	in	survival	rates	of	the	cells:	B16F1	
(P=.03),	RAW	264.7	(P=.012),	HepG2	(P=.005),	THP-	1	(P<.0001)
F IGURE  2 Long-	term	H. pylori	infection	of	positive	control	
(infected,	untreated)	mice.	Giemsa-	stained	gastric	specimens	five	weeks	
after	infection.	Arrows	show	H. pylori	foveolar	colonization	in	gastric	
fundus	sample	(Giemsa	staining;	OM	200×),	and	the	intra-	epithelial	
mononuclear	lymphoid	elements	of	the	mucosa	are	noted	(circles)
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3.3 | Effect of treatments on immune response
After	 confirmation	of	 the	 anti-	H. pylori	 activity	of	2MIX	 in	 vivo,	we	
	attempted	 to	 clarify	 the	 effect	 of	 2MIX	 as	 therapeutic	 agent	 on	
	immune	 response.	A	 set	of	40	 chemokines	 and	 cytokines	was	 ana-
lyzed	by	Proteome	Profiler	Array	in	serum	of	mice.	We	could	not	de-
tect	any	significant	changes	in	the	cytokine	profile	among	all	groups	
(Fig.	4),	 and	 this	 profile	was	 the	 same	with	 the	manufacturer’s	 ref-
erence	 	cytokine	profile	of	mouse	serum.	These	 results	 suggest	 that	
2MIX	do	not	have	any	immunomodulatory	or	allergic	effects	in	vivo.
3.4 | In vivo toxicity of 2MIX
We	 could	 not	 observe	 significant	 differences	 among	 groups	 in	 the	
case	of	the	liver	AST	and	ALT	enzyme	activities	because	NADH	levels	
were	comparable	between	all	groups	(Table	2).
Although	H. pylori	 infections	and	the	subsequent	treatments	had	
not	 changed	 the	 expression	 of	 Cyp3a11,	 the	 level	 of	 HO-	1	mRNA	
increased	after	the	H. pylori	 infections	and	decreased	again	after	the	
successful	 eradication	 of	 the	 pathogen	 in	 the	 2MIX	 treated	 group	
(Table	3).	 In	 conclusion,	 2MIX	was	 not	 toxic	 in	vivo,	 but	 only	HO-	1	
mRNA	showed	increased	expression	due	to	the	H. pylori	infection.
4  | DISCUSSIONS
This	study	primarily	aimed	to	investigate	the	in	vivo	anti-	H. pylori	effect	
of	the	2:1	mixture	of	S. hortensis	and	O. vulgare	subsp.	hirtum	essential	oils	
(2MIX),	as	our	previous	in	vitro	results	demonstrated	that	this	essential	oil	
mixture	would	be	a	highly	effective	therapeutic	agent	against	H. pylori.17
In	our	previous	in	vitro	experiments,	the	high	complexity	of	2MIX	
resulted	 in	 fourfold	 higher	 anti-	H. pylori	 activity	 than	 the	 individual	
oils	and	twofold	higher	activity	than	other	essential	oil	combinations,	
probably	due	to	the	increased	synergistic	effect	between	components	
of S. hortensis	and	O. vulgare	subsp.	hirtum	essential	oils.17	This	result	
came	as	no	surprise	as	other	recent	in	vitro	studies	also	demonstrated	
synergism	of	essential	oil	or	ethanol	plant	extract	mixtures	in	proven	
antibacterial,	antifungal,	or	antioxidant	activities.21–23
Namely,	essential	oils	are	complex	mixtures	of	numerous	volatile	
terpenoid	 compounds,	 from	which	all	 components	 and	 their	unique	
combinations	 greatly	 contribute	 to	 their	 antibacterial	 effects.	 It	 is	
	believed	that	terpenoids	could	have	an	impact	on	cell	penetration,	as	
well	as	lipophilic	or	hydrophilic	attraction	and	fixation	on	cell	walls	and	
membranes.24	Due	 to	 synergism	between	 terpenoids,	whole	 essen-
tial	oils	have	greater	antibacterial	activity	than	the	major	components	
alone.25–27
Contrary,	essential	oil	components	may	show	not	only	synergistic,	
but	also	antagonistic	effects	when	their	combination	has	lower	activ-
ity	 than	 the	 sum	of	 their	 individual	 effects.28	The	overall	 activity	of	
a	mixture	 probably	 depends	 on	 several	 factors	 such	 as	 the	 ratio	 of	
active	components,	the	characteristics	of	target	microorganisms,	and	
the	microenvironmental	factors	(e.g.,	pH	or	temperature).	For	example,	
Lambert	 et	al.29	 observed	 synergism	 between	 carvacrol	 and	 thymol	
investigating	 their	 antibacterial	 effect	 against	 Pseudomonas aerugi-
nosa	 and	 Staphylococcus aureus,	 while	 Falsafi	 et	al.26	 demonstrated	
antagonism	 between	 this	 two	 components	 studying	 anti-	H. pylori 
	activity.	Therefore,	a	mixture	of	essential	oils	is	not	necessarily	supe-
rior	to	the	individual	oils.30	Consequently,	combining	components	or	
whole	essential	oils	requires	detailed	considerations	and	preliminary	
experiments.
After	the	proven	outstanding	antibacterial	effect	of	2MIX	in	vitro,	
its	therapeutic	efficiency	was	investigated	in	the	present	in	vivo	study	
in	which	 Balb/c	 mice	were	 stably	 colonized	 by	H. pylori	 SS1	 strain.	
After	 oral	 treatments	with	 essential	 oils,	 70%	of	 the	 animals	 in	 the	
2MIX-	treated	 group	 had	 been	 completely	 cured.	What	 is	more	 this	
therapy	 did	 not	 cause	 any	 side	 effect	 or	 immune	 response	 in	mice,	
which	make	this	result	even	more	significant.	Namely,	absence	of	side	
effects	additionally	supports	further	in	vivo	and	potential	clinical	stud-
ies	which	could	promote	essential	oils	as	new	additional	therapy,	aside	
with	antibiotics,	for	patient	suffering	from	H. pylori	infection.
Facts	which	also	support	safe	anti-	H. pylori	usage	of	2MIX	in		humans	
are	that	investigated	oils	are	extensively	included	in	the	diet	and	folk	
medicine	since	ancient	time.	Namely,	people	worldwide	 traditionally	
use	Satureja	and	Origanum	species	as	herbal	teas	and	spices,31,32 while 
previous	 studies	 reported	 the	 potential	 of	 oregano	 essential	 oil	 to	
preserve	 food.33–35	 In	 traditional	medicine,	Greek	oregano	has	been	
F IGURE  3 Changes	in	the	level	of	H. pylori	colonization	after	treatments.	Agarose	gel	electrophoresis	of	PCR	products	showed	elimination	of	
the	bacteria	from	gastric	samples	of	the	2MIX-	treated	mice
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used	 to	 treat	 respiratory	 disorders,	 dyspepsia,	 painful	menstruation,	
rheumatoid	 arthritis,	 scrofulosis,	 and	 urinary	 tract	 disorders.32	 Also,	
summer	savory	is	a	traditional	remedy	for	treatment	of	various	symp-
toms,	such	as	muscle	pain,	stomach	and	intestinal	disorders—nausea,	
indigestion,	and	diarrhea,	as	well	as	various	infectious	diseases.31,36,37
However,	there	are	no	in	vivo	toxicology	studies	of	Greek	oregano	
essential	oils	on	humans.	Namely,	the	only	in	vivo	study	on	this	oil	was	
carried	out	by	Hollenbach	et	al.38	which	showed	that	oregano	essential	
oil	acted	directly	on	sexual	organs,	reducing	their	weight,	 	decreasing	
testosterone	levels,	and	causing	tissue	injury	of	the	testes	in	rats.	Still,	
these	 effects	 were	 observed	 after	 the	 treatment	 with	 much	 higher	
dose	of	essential	oil	(i.e.,	27%	v/v)	than	those	applied	in	our	study.
Concerning	summer	savory,	there	is	no	clinical	evidence	for	dose	
limitation.	 Also,	 contraindications,	 side	 effects,	 and	 potential	 drug	
interactions	 of	 this	 oil	 in	 humans	 have	 not	 been	 identified	 yet.39 
However,	in	single	animal	study,	it	is	determined	that	the	LD50	of	sum-
mer	savory	essential	oil	 is	1.37	g/kg	for	oral	administration,	which	is	
about	31	times	higher	than	concentration	applied	in	our	study.40
Results	of	this	study	are	of	great	value	especially	because	the	in	
vitro	anti-	H. pylori	 activity	of	different	essential	oils	was	previously	
demonstrated	 in	 several	 cases,	while	 studies	 on	 their	 in	 vivo	 effi-
ciency	are	scarce.	Specifically,	Ohno	et	al.15	reported	that	the	lemon	
grass	oil	significantly	reduced	the	bacterial	colonization	of	mice,	but	
only	10%	of	 the	animals	were	completely	cured.	 In	an	other	 study	
carried	out	by	Bergonzelli	et	al.,	only	a	subgroup	of	mice	responded	
to	 the	 examined	 carrot	 seed	 essential	 oil	 treatment.	 The	 therapy	
eradicated	the	pathogen	from	20%	to	30%	of	the	mice,	but	the	bac-
terial	 colonization	 did	 not	 significantly	 decrease	 in	 rest	 of	 the	 oil-	
treated	animals.16	Our	studies	indicate	that	2MIX	is	highly	effective	
in	vivo	 against	H. pylori,	 as	 70%	of	 the	mice	 had	 been	 cured	 after	
2MIX-	treatment.
In	 conclusion,	 these	 results	 suggest	 that	 the	 2:1	 mixture	 of	
 S.  hortensis	 and	 O. vulgare	 subsp.	 hirtum	 essential	 oils	 may	 have	
	potential	as	a	new,	effective,	and	safe	therapeutic	agent	against	H. py-
lori	 infections.	Synergistic	effects	between	their	compounds	increase	
the	antibacterial	efficiency	and	make	it	more	effective	than	the	individ-
ual	oils.	Above	all,	these	results	support	further	more	complex	inves-
tigation	toward	introduction	of	2MIX	into	official	clinical	anti-	H. pylori 
therapy.
F IGURE  4 Cytokine	profiles	of	pooled	serum	samples	in	each	
group.	(A)	−ctrl,	(B)	+ctrl,	(C)	sunflower	oil-	treated	group,	(D)	2MIX-	
treated	group.	Two	weeks	after	treatments,	the	production	of	
cytokines	has	not	changed	according	to	the	mouse	proteome	profiler	
array
A B C D
TABLE  2 Effect	of	orally	administered	2MIX	on	liver	AST	and	ALT	enzyme	activities
Group
AST activity ALT activity
NADH (mmol/min mg) P value NADH (mmol/min mg) P value
Positive	control 0.095	±	0.035 – 0.059	±	0.003 –
2MIX-	treated 0.118	±	0.059 .291 0.071	±	0.024 .137
Sunflower	oil-	treated 0.110	±	0.014 .335 0.071	±	0.014 .142
Negative	control 0.114	±	0.061 .741 0.062	±	0.012 .595
AST,	aspartate	aminotransferase;	ALT,	alanine	aminotransferase.
Given	P	values	denote	difference	from	the	positive	control	group.
TABLE  3 Effect	of	orally	administered	2MIX	on	liver	Cyp3a11	and	HO-	1	gene	expression	in	mice
Group
Cyp3a11/GAPDH HO- 1/GAPDH
Average normalized ratio P value Average normalized ratio P value
Positive	control 0.76	±	0.22 – 0.89	±	0.10 –
2MIX-	treated 0.66	±	0.25 .370 0.52	±	0.14 <.001
Sunflower	oil-	treated 0.75	±	0.28 .961 0.75	±	0.06 .038
Negative	control 0.40	±	0.36 .375 0.38	±	0.17 <.001
Cyp3a11,	cytochrome	P450,	family	3,	subfamily	a,	polypeptide	11;	HO-	1,	heme	oxygenase	1;	GAPDH,	glyceraldehyde-	3-	phosphate	dehydrogenase.
Given	P	values	denote	difference	from	the	positive	control	group.
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Abstract
In addition to traditional risk factors such as smoking habits and alcohol
consumption, certain microbes also play an important role in the generation
of head and neck carcinomas. Infection with high-risk human papillomavi-
rus types is strongly associated with the development of oropharyngeal
carcinoma, and Epstein-Barr virus appears to be indispensable for the
development of non-keratinizing squamous cell carcinoma of the nasophar-
ynx. Other viruses including torque teno virus and hepatitis C virus may act
as co-carcinogens, increasing the risk of malignant transformation. A shift
in the composition of the oral microbiome was associated with the devel-
opment of oral squamous cell carcinoma, although the causal or casual role
of oral bacteria remains to be clarified. Conversion of ethanol to acetalde-
hyde, a mutagenic compound, by members of the oral microflora as well as
by fungi including Candida albicans and others is a potential mechanism
that may increase oral cancer risk. In addition, distinct Candida spp. also
produce NBMA (N-nitrosobenzylmethylamine), a potent carcinogen.
Inflammatory processes elicited by microbes may also facilitate
tumorigenesis in the head and neck region.
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1 Introduction
Head and neck cancer is a broad term that
encompasses cancers arising in the head and neck
region. They may originate from the mucosal lin-
ing of the oral cavity, nasal cavity, paranasal
sinuses, oropharynx, nasopharynx, hypopharynx,
and larynx, or begin in the lip or in the salivary
glands (Bose et al. 2013). Most of these
malignancies are head and neck squamous cell
carcinomas (HNSCCs). Head and neck cancer is
the sixth most common cancer type worldwide
with approximately 650 000 new cases annually
(Ferlay et al. 2010). Despite the advancements of
treatment methods, including chemotherapy,
radiotherapy, and surgery, the 5-year survival rate
of HNSCC patients improved only modestly in the
past decades: it is around 50 %, mostly due to
locoregional recurrences, distant metastases and
additional primary tumors (Leemans et al. 2011).
The major risk factors for HNSCC are tobacco
use and alcohol consumption and they seem to
have a multiplicative combined effect. Genetic
polymorphisms in enzymes that metabolize
tobacco and alcohol have been linked to an
increased risk for HNSCC (Cadoni et al. 2012;
Maurya et al. 2014). Smokeless tobacco and
chewing of betel quid are also known risk factors
for oral cancer (Li et al. 2015; Sand et al. 2014).
There is wide geographic variation in the inci-
dence and anatomic distribution of HNSCC
worldwide. This variation is predominately
attributed to demographic differences in the
habits of tobacco use and alcohol consumption.
In the western part of the world the incidence of
HNSCC has declined, mostly due to the decline
of tobacco use. In contrast, oral cancer is the
leading type of malignancies among men in
high risk countries, such as India, Pakistan, Sri
Lanka and Bangladesh, (Joshi et al. 2014). Simi-
larly, the estimated incidence and mortality rate
of lip, oral cavity and pharynx carcinomas is high
in Central and Eastern European countries
(Hungary, Slovakia, Romania), possibly due to
traditional risk factors (Iriti and Varoni 2015).
According to the International Agency on
Research for Cancer (IARC), in 2008 around
two million of the estimated 12.7 million new
cancer cases occurring worldwide could be
attributed to infections (IARC Working Group
2012; de Martel et al. 2012). In addition to onco-
genic viruses (HPV, MCPyV, EBV, HHV-8,
HBV, HCV, HTLV-I) and bacteria (Helicobacter
pylori) other infectious agents may also contribute
to the development of malignant tumors. A series
of microbe-induced pathological alterations
including mutations, cell cycle modulation, inhi-
bition of DNA repair, epigenetic dysregulation,
inflammation and immune system impairment
may facilitate tumorigenesis (Alibek et al. 2013).
One of the well-documented virus-cancer
relationships is the association of high-risk
human papillomavirus (HPV) infection with a
subset of HNSCCs located predominantly to the
oropharynx. In the US andWestern Europe, there
was a recent increase in oropharyngeal cancer
incidence, compared to other head and neck
cancers. This phenomenon was attributed to a
higher prevalence of high-risk HPV strains in
the oral mucosa (Mehanna et al. 2013; Na¨sman
et al. 2009; Rietbergen et al. 2013).
The nearly ubiquitous Epstein-Barr virus (EBV)
plays a major role in the development of a series of
neoplasms including undifferentiated nasopharyn-
geal carcinoma (NPC). NPC is a rare cancer glob-
ally, but it is the leading cancer type in distinct
high-risk populations, especially in Southern
China, indicating that non-viral, genetic and envi-
ronmental factors also contribute to NPC develop-
ment (Jia and Qin 2012). Although compared to
HPV and EBV the evidence is less direct, recent
data also suggested a role for other viral, as well as
bacterial and fungal infections in the etiology of
head and neck cancer (Sand and Jalouli 2014).
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Carcinogenesis is a multistep process driven by
genetic and epigenetic alterations that result typi-
cally in the clonal or oligoclonal expansion of cells
(Hanahan and Weinberg 2000). Over 90 % of
HNSCCs arise from pre-existing potentially malig-
nant lesions or conditions, e.g. oral leukoplakia and
oral lichen planus. The treatment of high risk oral
premalignancies, however, did not efficiently pre-
vent either their recurrence or the development of
oral carcinomas (Braakhuis et al. 2003; Leemans
et al. 2011). This phenomenon was attributed to the
existence of a “field effect”, i.e. genetic alterations
predisposing large areas of oral mucosa for
tumorigenesis (‘field cancerization’). Recurrences
and novel new malignant transformations occur
preferentially at such ‘fields’ (Braakhuis
et al. 2003; Leemans et al. 2011). It is worthy to
note that epigenetic abnormalities characteristic for
laryngeal squamous cell carcinomas may also
extend to the adjacent normal mucosa, indicating
the occurrence of an “epigenetic field of
cancerisation” (Paluszczak et al. 2011).
We wish to overview the contribution of infec-
tious agents including viruses, bacteria and fungi
to the development of HNSCC. A better under-
standing of microbe-induced molecular events,
including genetic and epigenetic changes, in
head and neck cancer development may pave the
way for novel therapies and prevention strategies.
2 Human Papillomavirus
Human papillomaviruses (HPVs) of the
Papillomaviridae family are small,
non-enveloped viruses with a double-stranded, cir-
cular DNA genome of about 8000 bp. There are
174 completely characterized HPV types, classi-
fied on the basis of the capsid protein L1 gene
sequences (Bzhalava et al. 2013). The discovery
that distinct HPV typeswere associatedwith cervi-
cal carcinoma was a significant milestone in tumor
virology (reviewed by zur Hausen 2009).
HPVs have strict host selectivity for humans.
Cutaneous types infect the skin, whereas mucosal
types infect nonkeratinized squamous epithelia
lining the oral cavity, the esophagus and the
vagina. HPVs can be grouped into high and low
risk types based on their capacity to induce
malignant transformation. High risk types
include HPV 16, 18, 31, 33, 34, 35, 39, 45,
51, 52, 56, 58,59, 66, 68, 73 and 82; they were
associated with high grade intraepithelial lesions
of the cervix and with invasive cancer. In con-
trast, non-oncogenic or low-risk HPV types,
including HPV 6, 11, 40, 42, 43, 44, 54, 61,
72, 81 and 89, were detected in low grade
intraepithelial lesions (Woods et al. 2014).
HPV is associated with wide range of diseases
from benign warts to invasive cancer. There is
strong epidemiological evidence for the involve-
ment of HPV infection in the generation of six
non-skin cancer types, including the carcinomas
of cervix, penis, vulva, vagina, anus and upper
aerodigestive tract (de Martel et al. 2012). The
majority of HPV related head and neck cancers
are located to the oropharynx, an anatomic region
comprised of the soft palate, uvula, tonsils, poste-
rior pharyngeal wall, and the base of the tongue
(Gillison et al. 2014). It was suggested that tonsil-
lar crypts may trap the virus and inhibit mechani-
cal clearance. In addition, the monolayer of
epithelial cells that lines these crypts could be
more susceptible to HPV infection than stratified
epithelium (Elrefaey et al. 2014; Klussmann
et al. 2001). It is worthy to note that the oropha-
ryngeal SCCs associated with traditional risk
factors, i.e. smoking and alcohol consumption,
are usually moderately differentiated and show a
keratinizing phenotype. In contrast, the majority of
HPV-associated head and neck cancers lack signif-
icant keratinization and are of basaloid morphol-
ogy (Westra 2009).
3 The HPV Genome
All open reading frames in the 8 kb HPV genome
are located on one of the two DNA strands. Most
HPV-infected cells carry circular, episomal HPV
DNA molecules, whereas HPV-associated
carcinomas harbor viral genomes integrated into
the cellular DNA. The HPV genome can be
divided into three major regions. Early gene tran-
scription and replication is regulated by the long
control region (LCR) that contains promoter and
enhancer elements as well as the viral origin of
replication. The downstream coding ORFs are
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called early and late genes and their names refer
to their location as well as the timing of their
transcription. The products of the early genes
(E1-E7) are necessary for the genome mainte-
nance and replication. E5, E6 and E7 are the
oncoproteins of HPV, although they have their
important role in the normal lifecycle of the virus
as well. The E2 protein, apart from having a role
in genome replication, regulates the transcription
of the other early genes. The late genes (L1 and
L2) code for the structural proteins, with L1
being the major and L2 the minor capsid protein
(Rautava and Syrja¨nen 2012; Stanley 2012).
4 HPV Epidemiology
As for the prevalence of HPV in oropharyngeal
cancer cases, there are significant differences
between various anatomical regions. A recent
meta-analysis by Mehanna et al. found 47.7 %
overall pooled HPV prevalence in oropharyngeal
cancer, whereas 21.8 % of non-oropharyngeal
squamous cell carcinomas were HPV positive.
HPV prevalence was found to significantly
increase over time from 40,5 % before 2000 to
72,2 % after 2005. The overall HPV prevalence
of head and neck malignancies differed by geo-
graphical region as well: North-America and
Europe had the highest prevalence. In the last
decades Northern and Western European
countries have reported a steep rise in the pro-
portion of HPV associated oropharyngeal
cancers (Mehanna et al. 2013; Marur
et al. 2010; Na¨sman et al. 2009; Rietbergen
et al. 2013; Louie et al. 2015). However, regions
with low prevalence of HPV have reported lower
prevalence of HPV DNA in HNSCC patients
(Lopez et al. 2014), and similarly low prevalence
was found in relatively high-risk regions for
HNSCC, in Central-Europe and Latin-America.
In these communities traditional risk factors may
play a more important role in the development of
HNSCCs (Ribeiro et al. 2011; Marur et al. 2010).
HPV can be found in other types of head and
neck cancers as well. Isayeva et al. analyzed the
prevalence rates of HPV in oral cavity, laryngeal,
sinonasal and nasopharyngeal carcinomas. Lower
prevalence rates were detected (20.2 %, 23.6 %,
29.6 % and 31.1 %, respectively) compared to
oropharyngeal cancers (Isayeva et al. 2012). They
also found that the prevalence of HPV in poten-
tially premalignant and premalignant oral lesions
is significantly higher than the rate of oral HPV
carriers. Interestingly, submucous fibrosis showed
the highest HPV prevalence (11/12, 91.7 %).
Submucous fibrosis is a potentially malignant con-
dition of the oral cavity and it is linked to chewing
of betel quid (Jalouli et al. 2010).
Independently of overall HPV prevalence in
HNSCCs, HPV16 was the most abundant HPV
type found in these malignancies. HPV16
accounted for 86.7 % of HPV positive oropha-
ryngeal cancer; it was less prevalent, however, in
other types of head and neck cancer. A smaller
proportion was attributable to HPV18; other high
risk types were rarely found in these cancers
(Kreimer et al. 2005; Chaturvedi 2012). It was
observed that HPV associated oropharyngeal
cancers tend to have better prognosis than
HPV-positive carcinomas located to other ana-
tomic regions (Lindquist et al. 2007; Ang
et al. 2010; El-Mofty 2012, Mellin et al. 2012,
Sethi et al. 2012; Ramqvist et al. 2015).
5 Characteristics of Patients
with HPV-Associated Head
and Neck Cancer
People diagnosed with HPV related HNSCC tend
to be younger (<60 years of age) than those with
HNSCC caused by traditional risk factors
(>60 years of age) (Marur et al. 2010; Genden
et al. 2013). Although the absolute proportion of
HNSCC affecting young adults (18–40 years of
age) remains low (1–6 %), epidemiological stud-
ies have shown a steady rise in the incidence of
oropharyngeal and oral cavity cancer in this pop-
ulation (Majchrzak et al. 2014).
Several aspects of sexual behavior are
strongly associated with HPV positive HNSCC.
These include younger age at first intercourse,
total lifetime number of vaginal and oral sex
partners and lack of barrier use during sexual
intercourses (Gillison et al. 2008; Chaturvedi
2012; Burke et al. 2014).
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The incidence of both HPV-positive and
HPV-negative HNSCC are higher in men. The
male to female ratio has declined in oral cancer,
and now it is about 1.5:1; however in
HPV-associated HNSCC the male:female ratio
remains 3:1 (Gillison et al. 2012;
Warnakulasuriya 2009). This phenomenon can’t
be explained exclusively by the differences in
sexual behavior between the two genders, and
suggests some male predisposition to oropharyn-
geal cancer. It might be attributed to a protective
effect of seroconversion in women due to earlier
cervical HPV infection (Safaeian et al. 2010), or
to the higher oral HPV prevalence among men.
The latter is possibly due to a more effective
transmission of HPV through oral sex on
women versus men (Gillison et al. 2012).
6 HPV Induced Carcinogenesis:
Integration of the Viral
Genome into the Host
Cell DNA
After initial infection, the HPV genome persists
in episomal form within the host cells. Typically,
there is no integration of the viral genome into
the cellular DNA during productive infection of
differentiating epithelial cells. The virus relies on
the cellular replication machinery for the replica-
tion of its own genome (Lazarczyk et al. 2009).
Malignant transformation is associated with
high-level expression of viral E6 and E7
oncoproteins. During HPV-initiated carcinogen-
esis, high-level E6 and E7 expression frequently
occurs after the integration of the viral DNA into
the host cell genome (Vinokurova et al. 2008).
The integration breakpoint is usually within the
E2 gene encoding a negative regulator of E6 and
E7 transcription. Thus, the integration of the viral
genome disrupts the regulatory function of E2
and leads to constitutively active high-level E6
and E7 expression and increased cell prolifera-
tion (Parfenov et al. 2014; Williams et al. 2011;
Rautava and Syrja¨nen 2012). The integration
event also causes genomic instability by inducing
chromosomal rearrangements, DNA amplifica-
tion and disruption of tumor suppressor genes
(Parfenov et al. 2014). In certain neoplasms,
however, the HPV DNA can also be found in
episomal form, or there is a combination of
episomal and integrated form. In HPV16-
associated oropharyngeal cancer the episomal
or combined forms of viral genomes dominate.
In cases when HPV remained in episomal form, a
higher episomal count and a high viral load was
detected (Mellin et al. 2002; Deng et al. 2013;
Parfenov et al. 2014; Olthof et al. 2015).
7 HPV Oncoproteins
Three of the HPV proteins encoded by the early
region of the viral genome, E5, E6 and E7 were
implicated in carcinogenesis. The E5 gene is
frequently lost during integration and a large
fraction of HPV-associated tumors do not
express E5 protein (reviewed by Venuti
et al. 2011). E5 might contribute to oncogenesis,
however, in case of HPV genomes that persist as
episomes in tumor cells (Venuti et al. 2011). E5
may play a role in immune evasion by reducing
the MHC-I level on the cell surface (Sto¨ppler
et al. 1996; Campo et al. 2010). In addition, E5
may promote cell growth by enhancing epider-
mal growth factor receptor-mediated signaling
(DiMaio and Mattoon 2001).
In high-risk HPV-associated oropharyngeal
carcinoma cells, continuous expression of the
E6 and E7 oncoproteins is essential for the main-
tenance of the transformed phenotype (Rampias
et al. 2009). The mechanisms contributing to E6
and E7 mediated oncogenesis are complex. Here
we wish to outline only some of the best
documented carcinogenetic pathways.
E7 has neither direct DNA binding activity
nor enzymatic activity, but it is able to interact
with key cellular regulators. E7 binds and
induces the degradation of the retinoblastoma
protein (Rb), a tumor suppressor protein that
regulates the G1-S transition of the cell cycle
(reviewed by Rautava and Syrja¨nen 2012;
Boyer et al. 1996). Rb interacts with the E2F
family of transcription factors that activate
genes indispensable for S-phase entry and
progression (McLaughlin-Drubin and Mu¨nger
2010). Thus, binding of E7 to Rb results in con-
stitutive expression of E2F responsive genes and
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leads to DNA synthesis. Degradation of pRB
induces the upregulation of p16INK4A (p16)
tumor suppressor protein, and the elevated p16
level is used as a diagnostic marker in HPV
positive HNSCC (Fakhry et al. 2014). E7, a
pleiotropic regulator, also interacts with a series
of other cellular proteins involved in the control
of cell cycle and affects the gene expression
pattern of host cells by binding to key epigenetic
regulators (reviewed by Klingelhutz and Roman
2012; Moody and Laimins 2010).
The E6 protein of high-risk HPVs forms com-
plex with, and targets the tumor suppressor pro-
tein p53 for proteasomal degradation by
recruiting the cellular ubiquitin ligase E6AP. In
addition, the E6-p53 interaction interferes with
the binding of p53 to DNA and blocks p53 acet-
ylation (McLaughlin-Drubin and Mu¨nger 2010).
Because HPV-associated oropharyngeal cancers
harbor wild type, non-mutated p53 that has a
pro-apoptotic activity, it was suggested that
disrupting the E6-p53 complex may induce apo-
ptosis in HPV related malignancies (Li and John-
son 2013; Caicedo-Granados et al. 2014).
Genomic instability is an early event in
HPV-associated carcinogenesis (Moody and
Laimins 2010). In addition to the integration of
the HPV genome into the host cell DNA, HPV
E6 and E7 may also contribute to the develop-
ment of chromosomal aberrations, partly by
blocking p53, an important factor maintaining
the stability of the genome, and partly by induc-
ing centrosome abnormalities (McLaughlin-
Drubin and Mu¨nger 2010).
It is worthy to note that HPV directly inhibits
interferon synthesis and signaling via the inter-
action of E6 and E7 proteins with components of
the interferon signaling pathways (reviewed by
Stanley 2012). Such a mechanism may facilitate
the immune escape of HPV-positive carcinomas.
8 Epstein-Barr Virus: The First
Human Tumor Virus
Epstein-Barr virus (EBV), a human gammaher-
pesvirus, is associated with both lymphomas and
carcinomas, including Burkitt’s lymphoma (BL),
Hodgkin’s lymphoma, midline granuloma, post-
transplant lymphoproliferative disorders
(PTLDs), X-linked lymphoproliferative syn-
drome, nasopharyngeal carcinoma (NPC), gas-
tric carcinoma, and others (reviewed by Shah
and Young 2009; Sugden 2014). In
immunosuppressed and immunodeficient
patients, EBV-related leiomyosarcomas,
i.e. smooth muscle neoplasms may also develop
(Dalal et al. 2008). EBV, the first human tumor
virus, was discovered in BL cell cultures.
Although it was initially considered a purely
lymphotropic virus, an in situ hybridization
study of anaplastic NPCs revealed the presence
EBV DNA in the carcinoma cells, but not in
infiltrating lymphocytes, suggesting a role for
EBV in the malignant transformation of epithe-
lial cells, too (Epstein et al. 1964; Sugden 2014;
Wolf et al. 1973).
9 Estein-Barr Virus: Basic Facts
Epstein-Barr virus (EBV, also known as human
herpesvirus 4, HHV-4) belongs to the genus
Lymphocryptovirus within the subfamily
Gammaherpesvirinae of the familyHerpesviridae.
The prototype EBV genome is 172 kbp in length
and it is packaged into the virions as a linear DNA
molecule. Upon infection of B-lymphoid and epi-
thelial cells, the linear EBV genome undergoes
circularization, and latent EBV genomes typically
persist as circular episomes attached to the nuclear
matrix. Latent EBVepisomes co-replicatewith the
cellular DNA and display a restricted gene expres-
sion pattern. In contrast, all viral genes are
expressed and a large number of linear EBV
genomes are generated upon induction of lytic,
productive EBV replication. Depending on the
host cell phenotype, latent EBV genomes adopt
distinct gene expression patterns (latency types)
and the activity of latent viral promoters is
regulated by the cellular epigenetic machinery
(reviewed by Takacs et al. 2010). In turn, latent,
growth-transformation associated EBV proteins
affect the host cell transcriptome and epigenome
through the interaction with cellular epigenetic
regulators (reviewed by Niller et al. 2009).
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10 EBV and Nasopharymgeal
Carcinoma: Epidemiology
EBV is a ubiquitous herpesvirus spreading
among humans most commonly through saliva
and other bodily fluids. The majority of the pop-
ulation undergoes inapparent primary infection
in early childhood. The virus replicates in oro-
pharyngeal epithelial cells, but also infects B
lymphocytes, and latent EBV genomes are car-
ried by resting, memory B cells for life. Primary
EBV infection in teenagers or adults causes
infectious mononucleosis (IM, also called glan-
dular fever), a self-limiting disease (reviewed by
Niller et al. 2007; Sugden 2014).
Nasopharyngeal carcinoma was the first cancer
of the head and neck region that was found to be
associated with a human virus (Wolf et al. 1973).
There are two major types or classes of naso-
pharyngeal carcinoma, keratinizing squamous cell
carcinoma accounting for 20 % of NPC cases, and
non-keratinizing squamous cell carcinoma.
Keratinizing squamous cell carcinomas of the
nasopharynx occur sporadically throughout the
world at a relatively low incidence. They are
either EBV-positive or EBV negative, depending
on the geographical area (Nicholls et al. 1997).
The non-keratinizing type represents 80% of NPC
cases and it is invariably associated with EBV
(reviewed by Shah and Young 2009). Although
EBV infects human populations all over the
world, the incidence of the non-keratinizing type
of NPC, including both differentiated and undif-
ferentiated forms carrying latent EBV episomes in
almost 100 % of cases, occurs with a high inci-
dence at restricted geographical locations, i.e. it is
an endemic tumor in Southeast Asia, Tunisia, and
among Alaskan and Greenland Inuit (reviewed by
Shah and Young 2009; Niller et al. 2007).
11 Risk Factors Affecting
the Incidence
of Nasopharyngeal Carcinoma
Several genetic risk factors were identified in
China, especially in the Guangzhou area, that
may contribute to the high NPC incidence.
These include an allele encoding a member of
cytochrome-P450 super-family of proteins
involved in the activation of carcinogenic
compounds, a gene coding for a glutathione
S-transferase that contributes to the detoxifica-
tion of carcinogens, as well as genes located to or
near to HLA loci and genes encoding enzymes
and regulators of the DNA repair machinery
(reviewed by Lung et al. 2014; Niller
et al. 2007). It is worthy to note that epigenetic
inactivation of cellular genes, mainly by pro-
moter hypermethylation, also plays an important
role in the generation of NPC (reviewed by Niller
et al. 2014; Li et al. 2011).
Additional risk factors are volatile
nitrosamines that may act as initiators of chemi-
cal carcinogenesis and phorbol ester-like
compounds that may act as promoters,
stimulating the proliferation of cells carrying
mutated, initiated genomes. Such compounds
are present in medical herbal teas or in the diet,
including salted fish. Phorbol-ester-like
compounds such as diterpene-esters may also
induce lytic EBV replication, i.e. reactivation of
latent EBV genomes in B cells infiltrating the
nasopharyngeal epithelium (Ito et al. 1983; Ho
et al. 1978). Increased local EBV load may facil-
itate the infection of epithelial cells, an early
event in NPC development.
12 NPC: Carcinogenesis
As briefly outlined above, in addition to EBV
infection, genetic factors and environmental
carcinogens also play a role and act in concert
during the initiation and progression of NPC.
Based on these observations, Lo et al. elaborated
a collaborative model for NPC tumorigenesis
(Lo et al. 2012). They suggested that DNA dam-
age elicited by carcinogens (e.g. nitrosamines
from salted fish and preserved food) and local
chronic inflammation might cause chromosomal
aberrations that could be detected in the dysplastic
lesions of the nasopharynx. A typical finding was
the deletion of the short arm of chromosome
3 (3p) affecting several tumor suppressor genes.
In addition, epigenetic mechanisms such as pro-
moter hypermethylation also contribute to the
silencing of tumor suppressor genes already in
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EBV-negative dysplastic lesions. Centrosome
abnormalities and the generation of multipolar
spindles may also induce genetic instability at
this stage. Loss of the p16 tumor suppressor
gene may result in the overexpression of cyclin
D1 that favours stable latent EBV infection of
nasopharyngeal epithelial cells. EBV infection
and the clonal proliferation induced by latent
EBV proteins and RNAs may accelerate neoplas-
tic development (Lo et al. 2012).
Viral gene expression patterns of NPC typi-
cally corresponds to the so called latency type II.:
in addition to the nuclear protein EBNA1 (EBV
nuclear antigen 1), a variable expression of
LMP1 (latent membrane protein 1) and LMP2A
(latent membrane protein2A) is observed in NPC
(reviewed by Niller et al. 2007). LMP1 is an
oncoprotein, its expression in rodent cells results
in malignant transformation. The EBV genome
encodes non-translated microRNAs as well that
act as posttranscriptional regulators of mRNA
and protein levels. Hsu et al. observed that
miR-BART9 targets the E-cadherin mRNA and
promotes migration and metastasis formation by
NPC cells (Hsu et al. 2014).
13 Other Viruses Possibly
Associated with Head
and Neck Carcinomas and Oral
Precancerous Lesions: Torque
Teno Virus (TTV) and Hepatitis
C Virus (HCV)
TorqueTeno viruses (TTVs) belong to the family of
Anelloviridae and have a small, circular, single
stranded DNA genome (reviewed by Spandole
et al. 2015). Although the first TTV-like sequence
was found in the serum of a patient with post-
transfusion hepatitis, at present, TTV is not linked
to either hepatitis or any other disease as a causative
agent (Nishizawa et al. 1997; Okamoto 2009).
TTVs are ubiquitous viruses with a nearly 100 %
prevalence that establish persistent infection
(Saback et al. 1999; Hsieh et al. 1999; Zhong
et al. 2001; Ninomiya et al. 2008; Hussain
et al. 2012; Vasilyev et al. 2009). Children may be
infected by the end of their first year and simulta-
neous infections may also occur (Ninomiya
et al. 2008). TTVs can be found in wide range of
tissues and body fluids including liver, bone mar-
row, lymph nodes, spleen, pancreas, thyroid, lungs,
kidneys, PMBCs, saliva, urine, tears, nasal secre-
tion, feces, throat swabs, bile and semen (Spandole
et al. 2015). In addition, TTV related sequences
were detected in many different human diseases
including AIDS, neoplasia, asthma and rheumatoid
arthritis (Moen et al. 2002; Thom and Petrik 2007;
Pifferi et al. 2005; Sala´kova´ et al. 2009; Figueiredo
et al. 2007; Suzuki et al. 2014; de Villiers
et al. 2007; Gergely et al. 2006). Regarding head
and neck cancer, TTV related sequences were
found in laryngeal cancer (de Villiers et al. 2002).
Furthermore, co-infection with genogroup 1 TTV
andHPVwas associatedwith poor clinical outcome
of laryngeal carcinoma and the co-prevalence of
these viruses was significantly higher in lesions of
oral squamous cell cancer and oral lichen planus
compared to healthy mucosa (Szla´dek et al. 2005;
Fehe´r et al. 2009). TTV DNA activates Toll-like
receptor 9 (TLR9) and induces the production of
different pro-inflammatory cytokines. Thus, TTV
may affect the severity of diseaseswhere inflamma-
tion plays an important role (Rocchi et al. 2009;
Maggi and Bendinelli 2009). In addition, TTVs
encode a microRNA (TTV-tth8 miRNA) that
interferes with interferon signaling (Kincaid
et al. 2013). TTV-tth8 miRNA may play a role in
immune evasion by TTV and by TTV infected cells
by interacting with the mRNA of a regulatory pro-
tein, N-myc (and STAT) interactor (NMI) that
modulates interferon and cytokine signaling
(Kincaid et al. 2013).
Hepatitis C virus (HCV), an enveloped,
positive-sense single stranded RNA virus is a
member of the Flaviviridae family; HCV causes
chronic liver disease (Mohd Hanafiah et al. 2013).
HCV infection is also associated with several
extrahepatic manifestations (EHMs) (Zignego
et al. 2007). One of the EHMs is oral lichen planus
(OLP). It is worthy to note, however, that the
association of HCV infection and OLP was stron-
ger in Mediterranean countries and in Japan,
whereas in northern Europe OLP was not
associated with chronic liver disease caused by
HCV (Carrozzo 2008). OLP is a chronic inflam-
matory disease that affects the skin and also the
oral mucosa. The malignant transformation rate of
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OLP was found to be quite low (1.09 %); still, it
may play a role in the development of oral cancer
(Fitzpatrick et al. 2014).
Further studies may clarify the role of TTV
and HCV in HNSCC development.
Table 1 summarizes the viruses associated
with head and neck carcinomas.
14 Bacteria Associated with Head
and Neck Carcinoma
Although tobacco smoking, alcohol intake and
HPV16 infection appear to be major, indepen-
dent risk factors of a HNSCC, especially oral
carcinoma, a series of observations indicate that
oral bacteria and fungal infections of the oral
cavity may also be associated, either casually or
causally, with oral neoplasia. In a pioneering
study, Nagy et al. analysed the biofilm flora pres-
ent on the surfaces of oral squamous cell
carcinomas and on the contiguous healthy
mucosa (Nagy et al. 1998). They found a higher
number of both aerobic and anaerobic colony
forming units at the tumour sites than at the
apparently healthy mucosa. They also compared
the distribution of aerobic and anaerobic bacte-
rial species at these anatomical sites. The fre-
quency of most aerobic species was similar at
both sites, except Serratia liquefaciens, Klebsi-
ella pneumoniae, Citrobacter freundii, beta-
hemolyzing Streptococci, and Enterococcus
faecalis that were isolated more frequently from
the biofilm samples obtained from the surfaces of
oral carcinomas. Regarding anaerobic species,
the frequency of peptostreptococci and
lactobacilli was comparable at both sites,
whereas Actinomyces spp., Propionibacterium
spp., Clostridium spp., Veilonella spp.,
Fusobacterium spp., Prevotella spp.,
Porphyromonas spp., and Bacteriodes
ureolyticus/gracilis was isolated more frequently
from the tumor surface than from the control
mucosal surface (Nagy et al. 1998). It is worthy
to note that the fungus Candida albicans was
detected in a significant fraction of oral
carcinomas, but not at control sites (Nagy
et al. 1998). Nagy et al. concluded that the cancer
lesion itself may predispose patients with oral
carcinoma to both local and systemic infections
(Nagy et al. 1998). In a follow-up study, they
demonstrated that topical antimicrobial treat-
ment of oral squamous cell carcinoma lesions
effectively reduced the number of biofilm-
associated bacteria (Nagy et al. 2000). It is wor-
thy to note that radiotherapy or cytostatic treat-
ment of HNSCC patients also affected the
composition of oral microbiota, resulting in an
increased risk of local and systemic infections by
pathogenic or opportunistic microbes (reviewed
by Meurman 2010).
Hooper et al. aimed at the localization of
bacteria within a surface-decontaminated oral
squamous cell carcinoma (OSCC) sample; they
performed in situ hybridization with a FITC-
labeled oligonucleotide recognizing a sequence
within the 16S rRNA gene of Bacteria (Hooper
et al. 2007). They found bacteria throughout the
tumor tissue. Analysis of bacterial species by
PCR cloning and sequencing of the 16S rRNA
gene revealed that there was a trend for an
enrichment of Clavibacter michiganensis,
Fusobacterium naviforme, Ralstonia insidiosa
and Prevotella spp. in the tumor-derived samples
whereas control tissue samples were enriched in
Granulicatella adiacens, Porphyromonas
Table 1 Viruses associated with head and neck carcinoma
Virus Major viral oncoproteins Neoplasm or precancerous lesion
Human
papillomavirus
E6, E7 Oropharyngeal carcinoma, non-keratinizing; basaloid
phenotype
Epstein-Barr virus LMP1, LMP2A, EBNA1
(?)
Nasopharyngeal carcinoma, non-keratinizing type
Torque teno virus ? Laryngeal carcinoma (?)
Hepatitis C virus ? Oral lichen planus (?)
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gingivalis, Sphingomonas spp. and Streptococcus
mitis/oralis (Hooper et al. 2007). Hooper
et al. speculated the acidic and hypoxic microenvi-
ronment may select for the growth of certain bac-
terial species within tumors. They also raised the
point that tumor-associated bacteria may play a
role in carcinogenesis (Hooper et al. 2007). Others
also emphasized that in addition to Helicobacter
pylori, which is the causative agent of gastric car-
cinoma and gastric lymphoma in humans, other
bacterial species could also be involved in
tumorigenesis (Lax and Thomas 2002).
Pushalkar et al. used denaturing gradient gel
electrophoresis and 16S rRNA gene sequencing to
compare the oral microbiota of OSCC patients
(Pushalkar et al. 2012). There were no significant
differences in phylogenies at tumor and
non-tumor sites, although four Streptococcus spe-
cies as well as Peptostreptococcus stomatis,
Gemella haemolysans, Gemella morbillorum,
and Johnsonella ignova were highly associated
with the tumor site. At the non-tumor site
Granulicatella adiacens was prevalent. Pushalkar
et al. noticed site- specific and subject-specific
differences in the distribution of bacterial species.
They suggested that certain oral bacteria may
associate with different stages of OSCC and may
contribute to the acidic and hypoxic milieu char-
acteristic for neoplasms (Pushalkar et al. 2012).
Schmidt et al. performed pyrosequencing and
also next generation sequencing (using the
Illumina MiSeq instrument) to reveal the diver-
sity ofmicrobiomes in samples obtained by swab-
bing of oral cancer lesions and clinically normal
mucosal surfaces (Schmidt et al. 2014). Based on
the analysis of the V4 region of the bacterial 16S
rRNA genes, they classified 65,037 sequences at
the genus level and 17,115 sequences at the spe-
cies level. They observed a reduced abundance of
the phyla Firmicutes (especially Streptococcus)
and Actinobacteria (especially Rothia) in cancer
and pre-cancer samples compared to the
anatomically matched clinically normal patient
samples. In contrast, the proportion of
Fusobacteria increased at the tumor site.
Although there were inter-individual differences,
these changes appeared to be consistent. Schmidt
et al. argued that in spite of the diversity of the
oral microbial community, only distinct, biofilm-
forming oral bacteria adhere to oral tissues,
followed by secondary colonizers. They
suggested that altered surface properties at
OSCC lesions may affect the adherence of bacte-
ria, and a shift in bacterial populations may
induce inflammatory responses favouring tumor
progression (Schmidt et al. 2014). It is worthy to
note that Fusobacterium nucleatum, a Gram-
negative oral bacterium capable to invade the
oral mucosa, was recently implicated in colon
carcinogenesis (Castellarin et al. 2012; Kostic
et al. 2012, 2013).
Bebek et al. amplified, cloned and sequenced
variable regions 1–4 of the prokaryotic 16S rRNA
gene to characterize bacterial populations in
paired HNSCC and normal mucosa samples
(Bebek et al. 2012). They also analysed the
DNA methylation pattern of four cellular
promoters (MDR1, IL8, RARB, TGFBR2)
directing the expression of genes implicated in
inflammation and tumorigenesis. Interestingly,
hypermethylation of the MDR1 promoter, a phe-
nomenon regularly associated with promoter
silencing, correlated with the presence of bacteria
belonging to the Enterobacteriaceae family and
the Tenericutes phylum (Bebek et al. 2012).
MDR1 codes for multidrug resistance protein
1, a drug efflux pump for xenobiotic compounds
and MDR1 hypermethylation may contribute to
the progression of gastric carcinoma (Tahara
et al. 2009). Bebek et al. speculated that inflam-
matory processes elicited by bacteria may facili-
tate tumorigenesis by inducing hypermethylation
of distinct cellular promoters (Bebek et al. 2012).
It is worthy to note that the phylum Tenericutes
includes the generaMycoplasma and Ureaplasma
which are prevalent in oral samples from STD
patients (Nakashima et al. 2014). Others identified
Mycoplasma salivarium as a dominant colonizer
of oral carcinoma in two Fanconi anaemia
patients, and it was also observed that Myco-
plasma fermentans and Mycoplasma penetrans
induced malignant cell transformation in vitro
(Henrich et al. 2014; Tsai et al. 1995; Feng
et al. 1999; Zhang et al. 1997).
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The distribution of bacterial species detected
in the saliva may reflect the microbial diversity
of the soft tissues located in the oral cavity. Thus,
in principle, the salivary microbiota could be
used as a diagnostic marker of OSCC. Mager
et al. observed that the salivary counts of
Capnocytophaga gingivalis, Prevotella
melaninogenica, and Streptococcus mitis were
elevated in the saliva of OSCC patients com-
pared to the unstimulated saliva samples of
OSCC-free subjects (Mager et al. 2005). Mager
et al. speculated that alterations of tumor cell
receptors may facilitate the adherence of certain
bacteria and the resulting shift of soft tissue
microbiota in the oral cavity may affect the levels
of bacteria in the saliva (Mager et al. 2005). A
recent study also found a shift in the saliva
microbiome of OSCC patients: the most
prevalent genera were Streptococcus, Gemella,
Rothia, Peptostreptococcus, Lactobacillus,
and Porphyromonas. In contrast, in control
saliva samples Prevotella, Neisseria, Leptotrichia,
Capnocytophaga, Actinobacillus, and
Oribacterium dominated (Pushalkar et al. 2011).
Although the exact role of oral bacteria in car-
cinogenesis remains to be clarified, one potential
mechanism is the generation of carcinogenic
metabolites by certain oral bacteria (Meurman
and Uittamo 2008). It was demonstrated that both
non-pathogenic Neisseria strains and strains of
Streptococcus salivarius and Streptococcus
intermedius as well as Corynebacterium spp. and
Stomatococcus spp. are capable to convert ethanol
to acetaldehyde, a mutagenic and carcinogenic
substance (Muto et al. 2000; Homann et al. 2000;
Kurkivuori et al. 2007). Such a mechanism may
explain how poor dental status associated with
bacterial overgrowth may increase oral cancer
risk in patients with tooth loss, poor dentition and
inadequate oral hygiene (Homann et al. 2000,
2001). Homann et al. demonstrated an increase in
salivary acetaldehyde production from ethanol in
saliva samples of patients with poor dental status
(Homann et al. 2001).
Table 2 summarizes the bacteria associated
with head and neck carcinomas and their putative
role in carcinogenesis.
15 Fungi Associated with Head
and Neck Carcinoma
In parallel to the alterations of the bacterial flora
in oral cancer (see above), Nagy et al. described
the presence of Candida albicans in a significant
fraction of oral carcinomas, but not at control
sites (Nagy et al. 1998). Furthermore, similarly
to certain oral bacteria, it was documented that
both Candida albicans strains and non-Candida
albicans yeasts were capable of salivary acetal-
dehyde production from ethanol, and Candida
albicans could frequently be detected in oral
epithelial dysplasia, a premalignant lesion with
an increased risk of oral cancer (Tillonen
et al. 1999; McCullough et al. 2002; Nieminen
et al. 2009, reviewed by Sitheeque and
Samaranayake 2003; Bakri et al. 2010).
Chronic hyperplastic candidiasis (CHC, also
referred to as candidal leukoplakia) is a clinical
term for Candida-infected oral leukoplakias of
the oral mucosa that are characterized by hyphal
invasion and parakeratinosis. Although most fre-
quently Candida albicans could be detected in
CHC lesions, other species including Candida
dubliniensis, Candida tropicalis, Candida
pintolopesii, Candida glabrata and
Sacharomyces cerevisiae were also detected in
adherent chronic white patches of the oral
mucosa (Cernea et al. 1965; Jepsen and Winther
1965; Krogh et al. 1986, reviewed by Bakri
et al. 2010). C. albicans may either colonize
existing premalignant or malignant oral lesions,
or may promote the generation of precancerous
conditions and their progression to cancer
(Cernea et al. 1965; Jepsen and Winther 1965;
Nagy et al. 1998; Sitheeque and Samaranayake
2003; Bakri et al. 2010; Sanjaya et al. 2011). A
strong argument for a carcinogenic role of Can-
dida infection is the production of carcinogens
by certain Candida spp.: in addition to the muta-
genic acetaldehyde (see above), formation of the
potent carcinogen N-nitrosobenzylmethylamine
(NBMA) was also observed (Krogh et al. 1987;
Krogh 1990). Production of proteinases and
pro-inflammatory mediators by Candida spp.
may also contribute, indirectly, to carcinogenesis
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by degrading cell surface proteins, basement
membrane and extracellular matrix components
and by eliciting chronic inflammation (reviewed
by Bakri et al. 2010). Table 3 summarizes the
fungi associated with head and neck carcinomas
and their putative role in carcinogenesis
16 Conclusions
In the head and neck region, besides traditional
risk factors such as smoking habits and alcohol
consumption, certain microbes also play a role in
Table 2 Bacteria associated with oral carcinomas and their putative role in carcinogenesis or tumor progression
Bacterium Putative role Reference
Serratia liquefaciens ? Nagy et al. (1998)
Klebsiella pneumoniae ?
Citrobacter freundii ?
beta-hemolyzing
Streptococci
?
Enterococcus faecalis ?
Actinomyces spp. ?
Propionibacterium spp. ?
Clostridium spp. ?
Veilonella spp. ?
Fusobacterium spp. ?
Prevotella spp. ?
Porphyromonas spp. ?
Bacteriodes ureolyticus/
gracilis
?
Clavibacter
michiganensis
? Hooper et al. (2007)
Fusobacterium
naviforme
?
Ralstonia insidiosa ?
Prevotella spp. ?
Streptococcus spp. Contribution to the acidic and hypoxic milieu Pushalkar et al. (2012)
Peptostreptococcus
stomatis
Gemella haemolysans,
Gemella morbillorum
Johnsonella ignova
Fusobacterium spp. ? Schmidt et al. (2014)
Enterobacteriaceae
(family)
Induction of cellular promoter hypermethylation;
induction of pro-inflammatory changes
Bebek et al. (2012)
Tenericutes (phylum)
Streptococcus salivarius Conversion of ethanol to mutagenic acetaldehyde Muto et al. (2000), Homann
et al. (2000), Kurkivuori
et al. (2007)
Streptococcus
intermedius
Corynebacterium spp.
Stomatococcus spp.
Table 3 Fungi associated with oral carcinomas and their putative role in carcinogenesis
Fungus Putative role References
Candida spp. Salivary acetaldehyde production from ethanol Tillonen et al. (1999)
Formation of carcinogen (nitrosobenzylmethylamine, NBMA) Krogh et al. (1987), Krogh (1990)
A. Hettmann et al.
the generation of malignant epithelial tumors.
Infection with high-risk human papillomavirus
types is strongly associated with the development
of oropharyngeal carcinoma and Epstein-Barr
virus appears to be indispensable for the devel-
opment of non-keratinizing squamous cell carci-
noma of the nasopharynx. Infection with other
viruses including torque teno virus and hepatitis
C virus may increase the risk of initiation or
progression head and neck carcinomas. A shift
in the composition of the oral microbiome was
also associated with oral squamous cell carci-
noma, although the exact role of oral bacteria
remains to be clarified. Conversion of ethanol to
acetaldehyde, a mutagenic compound, by
members of the oral microflora as well as by
fungi including Candida albicans and others
may increase oral cancer risk. In addition, dis-
tinct Candida spp. also produce NBMA
(N-nitrosobenzylmethylamine), a potent carcino-
gen. Inflammatory processes elicited by
microbes may also facilitate tumorigenesis in
the head and neck region.
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